KR101694961B1 - small molecule asymmetric organic semiconductor compounds, its manufacturing method and organic semiconductor device using the same - Google Patents

small molecule asymmetric organic semiconductor compounds, its manufacturing method and organic semiconductor device using the same Download PDF

Info

Publication number
KR101694961B1
KR101694961B1 KR1020140060387A KR20140060387A KR101694961B1 KR 101694961 B1 KR101694961 B1 KR 101694961B1 KR 1020140060387 A KR1020140060387 A KR 1020140060387A KR 20140060387 A KR20140060387 A KR 20140060387A KR 101694961 B1 KR101694961 B1 KR 101694961B1
Authority
KR
South Korea
Prior art keywords
alkyl
group
formula
organic semiconductor
compound
Prior art date
Application number
KR1020140060387A
Other languages
Korean (ko)
Other versions
KR20140136892A (en
Inventor
문상진
신원석
이종철
이상규
황국비엣
Original Assignee
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국화학연구원 filed Critical 한국화학연구원
Publication of KR20140136892A publication Critical patent/KR20140136892A/en
Application granted granted Critical
Publication of KR101694961B1 publication Critical patent/KR101694961B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K10/00Organic devices specially adapted for rectifying, amplifying, oscillating or switching; Organic capacitors or resistors having a potential-jump barrier or a surface barrier

Abstract

본 발명은 단분자 유기 반도체 화합물과 이를 채용한 유기 반도체 장치를 제공하는 것으로, 본 발명의 단분자 유기 반도체 화합물은 중심골격에 상이한 구조의 치환기를 가져 전기적 특성과 용해도를 높여 이를 채용한 유기 반도체 장치는 우수한 효율을 가진다. The present invention provides a monomolecular organic semiconductor compound and an organic semiconductor device employing the monomolecular organic semiconductor compound. The monomolecular organic semiconductor compound of the present invention has a substituent having a different structure in its central skeleton to increase electrical characteristics and solubility, Have excellent efficiency.

Description

단분자 비대칭 유기 반도체 화합물, 이의 제조방법 및 이를 채용한 유기 반도체 장치{small molecule asymmetric organic semiconductor compounds, its manufacturing method and organic semiconductor device using the same}TECHNICAL FIELD [0001] The present invention relates to a single-molecule asymmetric organic semiconductor compound, a method of manufacturing the same, and an organic semiconductor device employing the organic semiconductor compound,

본 발명은 단분자 비대칭 유기 반도체 화합물, 이의 제조방법 및 이를 채용한 유기 반도체 장치에 관한 것이다.The present invention relates to a monomolecular asymmetric organic semiconductor compound, a method for producing the same, and an organic semiconductor device employing the same.

유기 반도체 화합물을 이용한 디바이스는, 종래의 무기 반도체 디바이스에 비하여 성막 조건이 까다롭지 않아, 각종 기판 위에 반도체 박막을 형성하거나, 상온에서 성막하거나 할 수 있으므로, 저비용화나, 폴리머필름 등에 박막을 형성함으로써 플렉시블화가 기대되고 있다.A device using an organic semiconductor compound is not as complicated in film forming conditions as compared with a conventional inorganic semiconductor device and can form a semiconductor thin film on various substrates or can be formed at room temperature and thus can be manufactured at a low cost or by forming a thin film on a polymer film, Anger is expected.

유기 반도체 화합물은, 예를 들어 유기 전계 효과 트랜지스터(OFET), 유기 발광 다이오드(OLED), 광검출기, 광전지(PV), 센서, 메모리 소자 및 논리 회로를 비롯하여 광범위한 소자 또는 장치에 적용되고 있다. Organic semiconductor compounds have been applied to a wide variety of devices or devices including, for example, organic field effect transistors (OFET), organic light emitting diodes (OLED), photodetectors, photovoltaic (PV), sensors, memory devices and logic circuits.

특히, 유기태양전지에서는 광활성층으로 도너 소재와 억셉터 소재를 함께 사용하는데, 고효율의 광전변환 성능을 나타내기 위해서는 도너 소재와 억셉터 소재의 도메인 크기가 매우 중용한 영향을 미친다. 현재 고효율의 광전변환 성능을 보여주는 도너 반도체 소재로는 대칭의 벤젠-디티오펜 구조를 가진 화합물이 많이 사용되어 왔다. 그러나 대칭 구조로는 모폴로지의 조절에 한계가 있다.In particular, in an organic solar cell, a donor material and an acceptor material are used together as a photoactive layer. In order to exhibit a photoelectric conversion performance with high efficiency, a domain size of a donor material and an acceptor material is extremely important. Currently, a compound having a symmetrical benzene-dithiophene structure has been used as a donor semiconductor material showing high efficiency of photoelectric conversion performance. However, symmetric structures have limitations in the control of morphology.

WO 2010-058692WO 2010-058692

본 발명은 신규한 단분자 비대칭 유기 반도체 화합물을 제공한다.The present invention provides novel monomolecular asymmetric organic semiconductor compounds.

또한 본 발명은 신규한 단분자 비대칭 유기 반도체 화합물의 제조방법을 제공한다.The present invention also provides a novel monomolecular asymmetric organic semiconductor compound.

또한 본 발명은 본 발명의 단분자 비대칭 유기 반도체 화합물을 채용한 유기 반도체 장치를 제공한다.The present invention also provides an organic semiconductor device employing the monomolecular asymmetric organic semiconductor compound of the present invention.

본 발명은 전기적 특성이 우수하고 용해도가 높아 용액공정기반에 적용 가능한 신규한 단분자 비대칭 유기 반도체 화합물을 제공한다.The present invention provides a novel monomolecular asymmetric organic semiconductor compound which is excellent in electrical characteristics and high in solubility and applicable to a solution process base.

본 발명의 단분자 비대칭 유기 반도체 화합물은 하기 화학식 1로 표시된다.The monomolecular asymmetric organic semiconductor compound of the present invention is represented by the following formula (1).

[화학식 1][Chemical Formula 1]

Figure 112014047294971-pat00001
Figure 112014047294971-pat00001

[상기 화학식 1에서,[In the above formula (1)

Z는 O, S 또는 Se이고;Z is O, S or Se;

R1은 (C1-C20)알킬, (C3-C20)시클로알킬, (C3-C20)헤테로시클로알킬, (C6-C20)아릴 또는 (C3-C20)헤테로아릴이며;R 1 is (C 1 -C 20) alkyl, (C 3 -C 20) cycloalkyl, (C 3 -C 20) heterocycloalkyl, (C 6 -C 20) aryl or (C 3 -C 20) heteroaryl;

R2는 (C1-C20)알킬, (C3-C20)시클로알킬, -((R1-1)i-O)j-R1-2 또는 -(R1-3)k-NR1-4R1-5이며,R 2 is (C1-C20) alkyl, (C3-C20) cycloalkyl, - (i -O (R 1-1 )) j -R 1-2 or - (R 1-3) k -NR 1-4 and R 1-5,

상기 R1-1 또는 R1-3은 서로 독립적으로 (C1-C10)알킬렌이며,Wherein R 1-1 or R 1-3 is independently (C1-C10) alkylene,

R1-2 및 R1-4 내지 R1-5는 서로 독립적으로 수소, (C1-C10)알킬 또는 (C1-C10)알콕시이며, i, j 및 k는 1 내지 5의 정수이며;R 1-2 and R 1-4 to R 1-5 are independently of each other hydrogen, (C 1 -C 10) alkyl or (C 1 -C 10) alkoxy; i, j and k are integers from 1 to 5;

A1 내지 A3 및 B1 내지 B3은 서로 독립적으로 (C6-C20)아릴렌 또는 (C3-C20)헤테로아릴렌이며;A 1 to A 3 and B 1 to B 3 independently of one another are (C 6 -C 20) arylene or (C 3 -C 20) heteroarylene;

R7 또는 R8은 서로 독립적으로 수소, (C1-C20)알킬, (C3-C20)시클로알킬, (C6-C20)아릴, (C3-C20)헤테로아릴, (C6-C20)아르(C1-C10)알킬 또는

Figure 112014047294971-pat00002
에서 선택되며;R 7 or R 8 are each independently hydrogen, (C1-C20) alkyl, (C3-C20) cycloalkyl, (C6-C20) aryl, (C3-C20) heteroaryl, (C6-C20) aralkyl (C1- C10) alkyl or
Figure 112014047294971-pat00002
Lt; / RTI >

n 또는 o는 1 내지 3의 정수이고;n or o is an integer from 1 to 3;

l, m, p 및 q는 0 내지 3의 정수이고;l, m, p and q are integers of 0 to 3;

R′은 수소 또는 (C1-C20)알킬이며;R 'is hydrogen or (C1-C20) alkyl;

상기 R1의 알킬기, 시클로알킬, 헤테로시클로알킬, 아릴 또는 헤테로아릴, R2의 알킬 또는 시킬로알킬, A1 내지 A3 B1 내지 B3의 아릴렌 또는 헤테로아릴렌, 및 R7 및 R8의 알킬, 시클로알킬, 아릴, 아르알킬 및 헤테로아릴은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]Alkyl group of the R 1, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, alkyl or to the R 2, A 1 to A 3, and B 1 to B 3 of the arylene or heteroarylene, and R 7 and R 8 alkyl, cycloalkyl, aryl, aralkyl and heteroaryl (C1-C20) alkyl, (C2-C20) alkenyl, (C2 -C20) alkynyl, (C1-C20) alkoxy, amino group, hydroxyl group, halogen group, cyano group, nitro group, trifluoromethyl group and silyl group.

본 발명의 단분자 비대칭 유기 반도체 화합물은 벤젠고리에 디퓨란, 디티오펜 또는 디셀레노펜이 융합된 구조, 즉, 벤조디퓨란, 벤조디티오펜 또는 벤조디셀레노펜 융합고리를 가져 높은 전자밀도로 인해 높은 전하이동도를 가진다.The monomolecular asymmetric organic semiconductor compound of the present invention has a structure in which a benzene ring is fused with a difuran, dithiophene or dicerenophen, that is, a benzodifuran, benzodithiophene or benzodiselenophene fused ring, High charge mobility.

또한 본 발명의 단분자 비대칭 유기 반도체 화합물은 벤조디퓨란, 벤조디티오펜 또는 벤조디셀레노펜 융합고리의 중심에 존재하는 벤젠에 서도 비대칭인 치환기를 가져 높은 개방전압을 가지며 몰폴로지(morphology) 조절이 가능하여 이를 채용한 유기 반도체 장치는 높은 효율을 가진다.The monomolecular asymmetric organic semiconductor compound of the present invention also has an asymmetric substituent in the benzene present in the center of the benzodifuran, benzodithiophene or benzodiselenophene fused ring to have a high open-circuit voltage and to control morphology And the organic semiconductor device employing the organic semiconductor device has high efficiency.

본 발명의 일 실시예에 따른 단분자 비대칭 유기 반도체 화합물은 이를 포함하는 유기 반도체 장치의 효율을 높이기 위한 측면에서 바람직하게는 상기 화학식 1에서 Z는 S이며, R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며, R2는 (C1-C20)알킬일 수 있다.In order to increase the efficiency of the organic semiconductor device including the monomolecular asymmetric organic semiconductor compound according to an embodiment of the present invention, Z is S in the formula (1), R 1 is (C 1 -C 20) alkyl or (C3-C20) heteroaryl, and R < 2 > may be (C1-C20) alkyl.

본 발명의 일 실시예에 따른 상기 화학식 1에서 A1 내지 A3 B1 내지 B3은 하기 구조에서 선택되는 것일 수 있다.In the formula (1), A 1 to A 3 and B 1 to B 3 may be selected from the following structures.

Figure 112014047294971-pat00003
Figure 112014047294971-pat00003

Figure 112014047294971-pat00004
Figure 112014047294971-pat00005
Figure 112014047294971-pat00004
Figure 112014047294971-pat00005

Figure 112014047294971-pat00006
Figure 112014047294971-pat00006

[상기 식에서,       [In the above formula,

Z는 O, S 또는 Se이고; Z is O, S or Se;

R11 내지 R43은 서로 독립적으로 수소, 할로겐, 하이드록시, 시아노, (C1-C20)알킬기, (C1-C20)알콕시기, (C6-C20)아르(C1-C10)알킬기이며;R 11 to R 43 independently represent hydrogen, halogen, hydroxy, cyano, (C 1 -C 20) alkyl, (C 1 -C 20) alkoxy or (C 6 -C 20) aryl (C 1 -C 10) alkyl;

a는 1 내지 4의 정수이며;a is an integer of 1 to 4;

b, e 및 f는 1 내지 2의 정수이고;b, e and f are integers of 1 to 2;

c 또는 d는 1 내지 3의 정수이다.]c or d is an integer of 1 to 3.]

본 발명의 일 실시예에 따른 단분자 비대칭 유기 반도체 화합물은 상기 화학식 1에서, Z는 S이며, R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며, R2는 (C1-C20)알킬이며, A1 내지 A3 B1 내지 B3은 하기 구조에서 선택되는 것일 수 있다.The monomolecular asymmetric organic semiconductor compound according to an embodiment of the present invention is represented by Formula 1 wherein Z is S, R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl, R 2 is (C 1 -C 20) C20) alkyl, A < 1 > to A < 3 & B 1 to B 3 may be selected from the following structures.

Figure 112014047294971-pat00007
Figure 112014047294971-pat00007

Figure 112014047294971-pat00008
Figure 112014047294971-pat00008

[상기 구조식에서,[In the above formula,

R11 내지 R29는 서로 독립적으로 수소, 할로겐, 하이드록시, 시아노, (C1-C20)알킬기, (C1-C20)알콕시기, (C6-C20)아르(C1-C10)알킬기이며;R 11 to R 29 independently represent hydrogen, halogen, hydroxy, cyano, (C 1 -C 20) alkyl, (C 1 -C 20) alkoxy or (C 6 -C 20) aryl (C 1 -C 10) alkyl;

b, e 및 f는 1 내지 2의 정수이다.]b, e and f are integers of 1 to 2.]

본 발명의 일 실시예에 따른 상기 화학식 1은 보다 바람직하게 하기 화학식 2 또는 3으로 표시될 수 있다.The formula (1) according to an embodiment of the present invention may more preferably be represented by the following formula (2) or (3).

[화학식 2](2)

Figure 112014047294971-pat00009
Figure 112014047294971-pat00009

[화학식 3](3)

Figure 112014047294971-pat00010
Figure 112014047294971-pat00010

[상기 화학식 2 및 3에서,[In the above formulas (2) and (3)

Z는 O, S 또는 Se이고;Z is O, S or Se;

R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며;R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl;

R2는 (C1-C20)알킬이며;R 2 is (C 1 -C 20) alkyl;

R3 내지 R6 및 R11은 서로 독립적으로 수소, (C1-C20)알킬기, (C6-C20)아르(C1-C10)알킬이며;
R 3 to R 6 and R 11 are independently of each other hydrogen, (C 1 -C 20) alkyl group, (C 6 -C 20) aryl (C 1 -C 10) alkyl;

A2, A3, B2 및 B3은 서로 독립적으로 (C6-C20)아릴렌 또는 (C3-C20)헤테로아릴렌이며;A 2 , A 3 , B 2 and B 3 are, independently of one another, (C6-C20) arylene or (C3-C20) heteroarylene;

R7 및 R8은 서로 독립적으로 수소, (C1-C20)알킬, (C3-C20)시클로알킬, (C6-C20)아릴, (C3-C20)헤테로아릴, (C6-C20)아르(C1-C10)알킬 또는

Figure 112014047294971-pat00011
에서 선택되며;R 7 and R 8 are independently of each other hydrogen, (C 1 -C 20) alkyl, (C 3 -C 20) cycloalkyl, (C 6 -C 20) aryl, (C 3 -C 20) heteroaryl, C10) alkyl or
Figure 112014047294971-pat00011
Lt; / RTI >

n 또는 o는 1 내지 3의 정수이고;n or o is an integer from 1 to 3;

l, m, p 및 q는 0 내지 3의 정수이고;l, m, p and q are integers of 0 to 3;

R′은 수소 또는 (C1-C20)알킬이며;R 'is hydrogen or (C1-C20) alkyl;

상기 R1의 알킬기, 시클로알킬, 헤테로시클로알킬, 아릴 또는 헤테로아릴, R2의 알킬 또는 시킬로알킬, A1 내지 A3 B1 내지 B3의 아릴렌 또는 헤테로아릴렌, 및 R7 및 R8의 알킬, 시클로알킬, 아릴, 아르알킬 및 헤테로아릴은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]Alkyl group of the R 1, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, alkyl or to the R 2, A 1 to A 3, and B 1 to B 3 of the arylene or heteroarylene, and R 7 and R 8 alkyl, cycloalkyl, aryl, aralkyl and heteroaryl (C1-C20) alkyl, (C2-C20) alkenyl, (C2 -C20) alkynyl, (C1-C20) alkoxy, amino group, hydroxyl group, halogen group, cyano group, nitro group, trifluoromethyl group and silyl group.

본 발명에 기재된 「알킬」, 「알콕시」 및 그 외 「알킬」부분을 포함하는 치환체는 직쇄 또는 분쇄 형태를 모두 포함한다. 또한 본 발명에 기재된 「아릴」은 하나의 수소 제거에 의해서 방향족 탄화수소로부터 유도된 유기 라디칼로, 각 고리에 적절하게는 4 내지 7개, 바람직하게는 5 또는 6개의 고리원자를 포함하는 단일 또는 융합고리계를 포함하며, 다수개의 아릴이 단일결합으로 연결되어 있는 형태까지 포함한다. 구체적인 예로 페닐, 나프틸, 비페닐, 안트릴, 인데닐(indenyl), 플루오레닐 등을 포함하지만, 이에 한정되지 않는다. 본 발명에 기재된 「헤테로아릴」은 방향족 고리 골격 원자로서 B, N, O, S, P(=O), Si 및 P로부터 선택되는 1 내지 4개의 헤테로원자를 포함하고, 나머지 방향족 고리 골격 원자가 탄소인 아릴 그룹을 의미하는 것으로, 5 내지 6원 단환 헤테로아릴 및 하나 이상의 벤젠환과 축합된 다환식 헤테로아릴이며, 부분적으로 포화될 수도 있으며, 일례로 티에노티에노펜, N-알킬 티에노피로-디온이 있다. 또한, 본 발명에서의 헤테로아릴은 하나 이상의 헤테로아릴이 단일결합으로 연결된 형태도 포함한다. The substituents comprising " alkyl ", " alkoxy " and other " alkyl " moieties described in this invention encompass both linear and branched forms. The term " aryl " in the present invention means an organic radical derived from an aromatic hydrocarbon by the removal of one hydrogen, and may be a single or fused ring containing 4 to 7, preferably 5 or 6 ring atoms, A ring system, and a form in which a plurality of aryls are connected by a single bond. Specific examples include, but are not limited to, phenyl, naphthyl, biphenyl, anthryl, indenyl, fluorenyl, and the like. "Heteroaryl" in the present invention includes 1 to 4 heteroatoms selected from B, N, O, S, P (= O), Si and P as aromatic ring skeletal atoms and the remaining aromatic ring skeletal atoms are carbon Means a 5 to 6 membered monocyclic heteroaryl and a polycyclic heteroaryl condensed with at least one benzene ring and may be partially saturated and includes, for example, thienothienophen, N-alkylthienopyrro-dione . The heteroaryl in the present invention also includes a form in which one or more heteroaryl is connected to a single bond.

또한 본 발명은 상기 화학식 1로 표시되는 신규한 단분자 비대칭 유기 반도체 화합물의 제조방법을 제공하며, 상기 화학식 1은 하기 화학식 4로 표시되는 화합물과 하기 화학식 5로 표시되는 화합물을 반응시켜 상기 화학식 1로 표시되는 유기 반도체 화합물을 제조하는 단계:를 포함할 수 있다.The present invention also provides a process for preparing a novel monomolecular asymmetric organic semiconductor compound represented by Formula 1, wherein the compound represented by Formula 1 is reacted with a compound represented by Formula 5, : ≪ / RTI >

[화학식 4][Chemical Formula 4]

Figure 112014047294971-pat00012
Figure 112014047294971-pat00012

[화학식 5][Chemical Formula 5]

Figure 112014047294971-pat00013
Figure 112014047294971-pat00013

[상기 화학식 4 및 5에서,[In the above formulas (4) and (5)

Z는 O, S 또는 Se이고;Z is O, S or Se;

R1은 (C1-C20)알킬, (C3-C20)시클로알킬, (C3-C20)헤테로시클로알킬, (C6-C20)아릴 또는 (C3-C20)헤테로아릴이며;R 1 is (C 1 -C 20) alkyl, (C 3 -C 20) cycloalkyl, (C 3 -C 20) heterocycloalkyl, (C 6 -C 20) aryl or (C 3 -C 20) heteroaryl;

R2는 (C1-C20)알킬, (C3-C20)시클로알킬, -((R1-1)i-O)j-R1-2 또는 -(R1-3)k-NR1-4R1-5이며,R 2 is (C1-C20) alkyl, (C3-C20) cycloalkyl, - (i -O (R 1-1 )) j -R 1-2 or - (R 1-3) k -NR 1-4 and R 1-5,

상기 R1-1 또는 R1-3은 서로 독립적으로 (C1-C10)알킬렌이며,Wherein R 1-1 or R 1-3 is independently (C1-C10) alkylene,

R1-2 및 R1-4 내지 R1-5은 서로 독립적으로 수소, (C1-C10)알킬 또는 (C1-C10)알콕시이며, i, j 및 k는 1 내지 5의 정수이며;R 1-2 and R 1-4 to R 1-5 are independently of each other hydrogen, (C 1 -C 10) alkyl or (C 1 -C 10) alkoxy, i, j and k are integers from 1 to 5;

R7 또는 R8은 서로 독립적으로 수소, (C1-C20)알킬, (C3-C20)시클로알킬, (C6-C20)아릴, (C3-C20)헤테로아릴, (C6-C20)아르(C1-C10)알킬 또는

Figure 112014047294971-pat00014
에서 선택되며;R 7 or R 8 are each independently hydrogen, (C1-C20) alkyl, (C3-C20) cycloalkyl, (C6-C20) aryl, (C3-C20) heteroaryl, (C6-C20) aralkyl (C1- C10) alkyl or
Figure 112014047294971-pat00014
Lt; / RTI >

R′은 수소 또는 (C1-C20)알킬이며;R 'is hydrogen or (C1-C20) alkyl;

A1 내지 A3 은 서로 독립적으로 (C6-C20)아릴렌 또는 (C3-C20)헤테로아릴렌이며,A 1 to A 3 independently of one another are (C 6 -C 20) arylene or (C 3 -C 20) heteroarylene,

n은 1 내지 3의 정수이고;n is an integer from 1 to 3;

l 또는 m은 0 내지 3의 정수이고;l or m is an integer of 0 to 3;

T는 Sn(R51)(R52)(R53)이며, R51 내지 R53 (C1-C10)알킬이며;T is Sn (R 51 ) (R 52 ) (R 53 ), R 51 to R 53 are (C1-C10) alkyl;

X는 할로겐이며;X is halogen;

상기 R1의 알킬기, 시클로알킬, 헤테로시클로알킬, 아릴 또는 헤테로아릴, R2의 알킬 또는 시킬로알킬, A1 내지 A3의 아릴렌 또는 헤테로아릴렌, 및 R7의 알킬, 시클로알킬, 아릴, 아르알킬 및 헤테로아릴은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]Alkyl group of the R 1, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, alkyl or to the R 2, A 1 to A 3 of the arylene or heteroarylene, and R 7, cycloalkyl, aryl (C2-C20) alkynyl, (C1-C20) alkoxy, an amino group, a hydroxyl group, a halogen group, a cyano group, A nitro group, a trifluoromethyl group, and a silyl group.

본 발명의 일 실시예에 따른 상기 화학식 1의 제조방법에서 화학식 4의 화합물을 화학식 5의 화합물과 반응시킬 때 생성된 화학식 1의 치환기인

Figure 112014047294971-pat00015
Figure 112014047294971-pat00016
와 동일하거나 상이한 치환기일 수 있다. In the process for preparing the compound of formula 1 according to an embodiment of the present invention, the compound of formula 4 is reacted with the compound of formula 5,
Figure 112014047294971-pat00015
The
Figure 112014047294971-pat00016
May be the same or different.

또한 본 발명은 하기 화학식 4로 표시되는 화합물과 하기 화학식 5-1로 표시되는 화합물을 반응시켜 하기 화학식 5-2의 화합물을 제조하고 하기 화학식 5-2의 화합물과 하기 화학식 5-3의 화합물을 반응시켜 상기 화학식 1의 유기 반도체 화합물을 제조하는 단계;를 포함하는 유기 반도체 화합물의 제조방법을 제공한다.The present invention also relates to a process for preparing a compound represented by the following formula (5-2) by reacting a compound represented by the following formula (4) with a compound represented by the following formula (5-1) And then reacting the organic semiconductor compound to produce an organic semiconductor compound.

[화학식 4][Chemical Formula 4]

Figure 112014047294971-pat00017
Figure 112014047294971-pat00017

[화학식 5-1][Formula 5-1]

Figure 112014047294971-pat00018
Figure 112014047294971-pat00018

[화학식 5-2][Formula 5-2]

Figure 112014047294971-pat00019
Figure 112014047294971-pat00019

[화학식 5-3][Formula 5-3]

R7-1-HR 7-1 -H

[상기 화학식 1, 4, 5-1 내지 5-3에서,[In the formulas (1), (4) and (5-1) to (5-3)

Z는 O, S 또는 Se이고;Z is O, S or Se;

R1은 (C1-C20)알킬, (C3-C20)시클로알킬, (C3-C20)헤테로시클로알킬, (C6-C20)아릴 또는 (C3-C20)헤테로아릴이며;R 1 is (C 1 -C 20) alkyl, (C 3 -C 20) cycloalkyl, (C 3 -C 20) heterocycloalkyl, (C 6 -C 20) aryl or (C 3 -C 20) heteroaryl;

R2는 (C1-C20)알킬, (C3-C20)시클로알킬, -((R1-1)i-O)j-R1-2 또는 -(R1-3)k-NR1-4R1-5이며,R 2 is (C1-C20) alkyl, (C3-C20) cycloalkyl, - (i -O (R 1-1 )) j -R 1-2 or - (R 1-3) k -NR 1-4 and R 1-5,

상기 R1-1 또는 R1-3은 서로 독립적으로 (C1-C10)알킬렌이며,Wherein R 1-1 or R 1-3 is independently (C1-C10) alkylene,

R1-2 및 R1-4 내지 R1-5은 서로 독립적으로 수소, (C1-C10)알킬 또는 (C1-C10)알콕시이며, i, j 및 k는 1 내지 5의 정수이며;R 1-2 and R 1-4 to R 1-5 are independently of each other hydrogen, (C 1 -C 10) alkyl or (C 1 -C 10) alkoxy, i, j and k are integers from 1 to 5;

R7 또는 R8은 서로 독립적으로 수소, (C1-C20)알킬, (C3-C20)시클로알킬, (C6-C20)아릴, (C3-C20)헤테로아릴, (C6-C20)아르(C1-C10)알킬 또는

Figure 112014047294971-pat00020
에서 선택되며;R 7 or R 8 are each independently hydrogen, (C1-C20) alkyl, (C3-C20) cycloalkyl, (C6-C20) aryl, (C3-C20) heteroaryl, (C6-C20) aralkyl (C1- C10) alkyl or
Figure 112014047294971-pat00020
Lt; / RTI >

R′은 수소 또는 (C1-C20)알킬이며;R 'is hydrogen or (C1-C20) alkyl;

R7-1은 (C1-C20)알킬, (C2-C20)알케닐, (C3-C20)헤테로시클로알킬, (C6-C20)아릴, (C3-C20)헤테로아릴, (C6-C20)아르(C1-C20)알킬 또는

Figure 112014047294971-pat00021
이며;R 7-1 is selected from (C 1 -C 20) alkyl, (C 2 -C 20) alkenyl, (C 3 -C 20) heterocycloalkyl, (C 6 -C 20) aryl, (C 3 -C 20) heteroaryl, (C1-C20) alkyl or
Figure 112014047294971-pat00021
;

A1 내지 A3 및 B1 내지 B3은 서로 독립적으로 (C6-C20)아릴렌 또는 (C3-C20)헤테로아릴렌이며,A 1 to A 3 and B 1 to B 3 independently of one another are (C6-C20) arylene or (C3-C20) heteroarylene,

n 또는 o는 1 내지 3의 정수이고;n or o is an integer from 1 to 3;

l, m, p 및 q는 0 내지 3의 정수이고;l, m, p and q are integers of 0 to 3;

T는 Sn(R51)(R52)(R53)이며, R51 내지 R53 (C1-C10)알킬이며;T is Sn (R 51 ) (R 52 ) (R 53 ), R 51 to R 53 are (C1-C10) alkyl;

X는 할로겐이며;X is halogen;

상기 R1의 알킬기, 시클로알킬, 헤테로시클로알킬, 아릴 또는 헤테로아릴, R2의 알킬 또는 시킬로알킬, A1 내지 A3 B1 내지 B3의 아릴렌 또는 헤테로아릴렌, R7 및 R8의 알킬, 알케닐, 시클로알킬, 아릴, 아르알킬 및 헤테로아릴 및 R7-1의 알킬, 알케닐, 헤테로시클로알킬, 아릴, 헤테로아릴 및 (C6-C20)아르(C1-C20)알킬은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, (C3-C20)시클로알킬, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]Alkyl group of the R 1, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, alkyl or to the R 2, A 1 to A 3, and B 1 to B 3 of the arylene or heteroarylene, R 7 and R 8 alkyl, alkenyl, cycloalkyl, aryl, aralkyl and heteroaryl alkyl, and R 7-1, alkenyl, heterocycloalkyl, aryl (C1-C20) alkyl, (C2-C20) alkenyl, (C2-C20) alkynyl, C20) cycloalkyl, an amino group, a hydroxyl group, a halogen group, a cyano group, a nitro group, a trifluoromethyl group and a silyl group.

본 발명의 일 실시예에 따른 상기 화학식 1의 유기 반도체 화합물의 제조방법에서, 상기 화학식 4의 화합물은 하기 화학식 6로 표시되는 화합물을 화학식 7 또는 화학식 8과 반응시켜 제조될 수 있다.In the process for preparing an organic semiconductor compound of Formula 1 according to an embodiment of the present invention, the compound of Formula 4 may be prepared by reacting a compound of Formula 6 with a compound of Formula 7 or Formula 8.

[화학식 6][Chemical Formula 6]

Figure 112014047294971-pat00022
Figure 112014047294971-pat00022

[화학식 7](7)

(X1)Sn(R51)(R52)(R53)(X 1 ) Sn (R 51 ) (R 52 ) (R 53 )

[화학식 8][Chemical Formula 8]

(R54)(R55)(R56)Sn-Sn(R51)(R52)(R53)( R57 ) ( R56 ) ( R56 ) Sn-Sn ( R51 ) ( R52 ) ( R53 )

[상기 화학식 6 내지 화학식 8에서,[In the above Chemical Formulas 6 to 8,

Z는 O, S 또는 Se이고;Z is O, S or Se;

R1은 (C1-C20)알킬, (C3-C20)시클로알킬, (C3-C20)헤테로시클로알킬, (C6-C20)아릴 또는 (C3-C20)헤테로아릴이며;R 1 is (C 1 -C 20) alkyl, (C 3 -C 20) cycloalkyl, (C 3 -C 20) heterocycloalkyl, (C 6 -C 20) aryl or (C 3 -C 20) heteroaryl;

R2는 (C1-C20)알킬, (C3-C20)시클로알킬, -((R1-1)i-O)j-R1-2 또는 -(R1-3)k-NR1-4R1-5이며,R 2 is (C1-C20) alkyl, (C3-C20) cycloalkyl, - (i -O (R 1-1 )) j -R 1-2 or - (R 1-3) k -NR 1-4 and R 1-5,

상기 R1-1 또는 R1-3은 (C1-C10)알킬렌이며,Wherein R 1-1 or R 1-3 is (C 1 -C 10) alkylene,

R1-2 및 R1-4 내지 R1-5은 서로 독립적으로 수소, (C1-C10)알킬 또는 (C1-C10)알콕시이며, i, j 및 k는 1 내지 5의 정수이며;R 1-2 and R 1-4 to R 1-5 are independently of each other hydrogen, (C 1 -C 10) alkyl or (C 1 -C 10) alkoxy, i, j and k are integers from 1 to 5;

X1은 할로겐이며;X 1 is halogen;

R51 내지 R56 서로 독립적으로(C1-C10)알킬이며;R 51 - R 56 is Independently of one another are (C1-C10) alkyl;

상기 R1의 알킬기, 시클로알킬, 헤테로시클로알킬, 아릴 또는 헤테로아릴, R2의 알킬 또는 시킬로알킬, R51 내지 R56의 알킬은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]Alkyl group of the R 1, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, alkyl or to the R 2, R 51 to The alkyl of R 56 is selected from the group consisting of (C 1 -C 20) alkyl, (C 2 -C 20) alkenyl, (C 2 -C 20) alkynyl, A trifluoromethyl group, and a silyl group.]

본 발명의 일 실시예에 따른 상기 화학식 6은 하기 화학식 9로 표시되는 화합물과 하기 화학식 10를 반응시켜 하기 화학식 11을 제조하는 단계; 및(6) may be prepared by reacting a compound represented by the following formula (9) with the following formula (10) to prepare a compound of formula (11); And

상기 화학식 11을 하기 화학식 12와 반응시켜 상기 화학식 6을 제조하는 단계;를 포함하여 제조될 수 있다.And reacting the compound of formula (11) with a compound of formula (12) to prepare the compound of formula (6).

[화학식 9][Chemical Formula 9]

Figure 112014047294971-pat00023
Figure 112014047294971-pat00023

[화학식 10][Chemical formula 10]

R1MX2 R 1 MX 2

[화학식 11](11)

Figure 112014047294971-pat00024
Figure 112014047294971-pat00024

[화학식 12][Chemical Formula 12]

R2X3 R 2 X 3

[상기 화학식 9 내지 12에서, [In the above formulas (9) to (12)

Z는 O, S 또는 Se이며; Z is O, S or Se;

R1은 (C1-C20)알킬, (C3-C20)시클로알킬, (C3-C20)헤테로시클로알킬, (C6-C20)아릴 또는 (C3-C20)헤테로아릴이며;R 1 is (C 1 -C 20) alkyl, (C 3 -C 20) cycloalkyl, (C 3 -C 20) heterocycloalkyl, (C 6 -C 20) aryl or (C 3 -C 20) heteroaryl;

R2는 (C1-C20)알킬, (C3-C20)시클로알킬, -((R1-1)i-O)j-R1-2 또는 -(R1-3)k-NR1-4R1-5이며,R 2 is (C1-C20) alkyl, (C3-C20) cycloalkyl, - (i -O (R 1-1 )) j -R 1-2 or - (R 1-3) k -NR 1-4 and R 1-5,

상기 R1-1 또는 R1-3은 서로 독립적으로 (C1-C10)알킬렌이며,Wherein R 1-1 or R 1-3 is independently (C1-C10) alkylene,

R1-2 및 R1-4 내지 R1-5는 서로 독립적으로 수소, (C1-C10)알킬 또는 (C1-C10)알콕시이며, i, j 및 k는 1 내지 5의 정수이며;R 1-2 and R 1-4 to R 1-5 are independently of each other hydrogen, (C 1 -C 10) alkyl or (C 1 -C 10) alkoxy; i, j and k are integers from 1 to 5;

M은 알칼리금속 또는 알칼리토금속이며;M is an alkali metal or an alkaline earth metal;

X2 또는 X3은 서로 독립적으로 할로겐이며;X 2 or X 3 independently of one another are halogen;

상기 R1의 알킬, 사이클로알킬, 헤테로사이클로알킬, 아릴 또는 헤테로아릴 및 R2의 알킬 또는 사이킬로알킬은 할로겐, (C1-C10)알킬, (C1-C10)알콕시, 아미노, 하이드록시 또는 나이트로에서 선택되는 하나이상으로 더 치환될 수 있다.]Said alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl, and alkyl, or between kilo alkyl of R 2 in R 1 is halogen, (C1-C10) alkyl, (C1-C10) alkoxy, amino, hydroxy or nitro ≪ / RTI >

본 발명의 일 실시예에 따른 상기 화학식 1로 표시되는 단분자 비대칭 유기 반도체 화합물을 제조하는 방법에서 반응온도와 반응시간은 한정이 있는 것은 아니며, 상기 화학식 6으로 표시되는 화합물을 제조하는 단계와 상기 화학식 9로 표시되는 화합물과 상기 화학식 10을 반응시켜 하기 화학식 11을 제조하는 단계는 각각 상온, 15 내지 35℃에서 5시간 내지 30시간동안 수행될 수 있으며, 상기 화학식 11을 상기 화학식 12와 반응시켜 상기 화학식 6을 제조하는 단계는 80 내지 110℃에서 2시간 내지 12시간동안 수행될 수 있다.The reaction temperature and the reaction time are not limited in the method of preparing the monomolecular asymmetric organic semiconductor compound represented by Formula 1 according to an embodiment of the present invention, The step of reacting the compound represented by the formula (9) with the compound of the formula (10) to produce the compound of the formula (11) can be carried out at room temperature and 15 to 35 ° C for 5 hours to 30 hours, respectively. The step of preparing the compound of Formula 6 may be carried out at 80 to 110 ° C for 2 to 12 hours.

본 발명의 일실시예에 따른 화학식 10에서 M은 알칼리금속 또는 알칼리토금속으로 바람직하게는 알칼리토금속일 수 있으며, 일례로 Mg일 수 있다.In formula (10) according to an embodiment of the present invention, M may be an alkali metal or an alkaline earth metal, preferably an alkaline earth metal, for example Mg.

본 발명의 제조방법에서 사용되는 용매는 통상의 유기용매이면 모두 가능하나, 다이클로로메탄(DCM), 다이클로로에탄(DCE), 톨루엔(Toluene), 아세토나이트릴(MeCN), 나이트로 메탄(Nitromethan), 테트라하이드로퓨란(THF), N,N-다이메틸 포름아마이드 (DMF) 및 N,N-다이메틸아세트아마이드(DMA)로 이루어진 군으로부터 선택되는 1종 이상일 수 있다.The solvent used in the production method of the present invention can be any conventional organic solvent but may be any solvent such as dichloromethane, DCE, toluene, acetonitrile, ), Tetrahydrofuran (THF), N, N -dimethylformamide (DMF) and N, N -dimethylacetamide (DMA).

반응온도는 통상의 유기합성에서 사용되는 온도에서 사용가능하나, 반응시간 반응물질 및 출발물질의 양에 따라 달라질 수 있으며, TLC 등을 통하여 출발물질이 완전히 소모됨을 확인한 후 반응을 완결시키도록 한다. 반응이 완결되면 추출과정 후 감압 하에서 용매를 증류시킨 후 관 크로마토그래피 등의 통상적인 방법을 통하여 목적물을 분리 정제할 수도 있다.The reaction temperature can be used at the temperature used in conventional organic synthesis, but it can be varied depending on the amount of the reaction material and the starting material, and the reaction is completed after confirming that the starting material is completely consumed through TLC or the like. When the reaction is completed, the solvent may be distilled off under reduced pressure after the extraction process, and then the target product may be separated and purified through a conventional method such as column chromatography.

또한 본 발명은 본 발명의 단분자 비대칭 유기 반도체 화합물을 함유하는 유기 반도체 장치를 제공한다.The present invention also provides an organic semiconductor device containing a monomolecular asymmetric organic semiconductor compound of the present invention.

본 발명의 단분자 비대칭 유기 반도체 화합물은 유기 반도체 화합물이 단분자로 높은 순도를 가져 전기특성이 우수할 뿐만 아니라 단분자 비대칭 유기 반도체 화합물의 중심골격에 서로 비대칭인 치환기를 가져 몰폴리지(morphology) 조절이 가능하고 높은 전하이동도를 가진다.The monomolecular asymmetric organic semiconducting compound of the present invention is an organic semiconducting compound having a high purity as a single molecule and having excellent electrical characteristics as well as having a substituent which is asymmetric with respect to the central skeleton of the monomolecular asymmetric organic semiconductor compound, And has high charge mobility.

또한 본 발명의 단분자 비대칭 유기 반도체 화합물은 용해도가 높아 용액공정기반에 적용이 가능하여 경제적으로 대면적화가 가능하다.In addition, since the monomolecular asymmetric organic semiconductor compound of the present invention has high solubility, it can be applied to a solution process base, thereby making it economically large-scale.

또한 본 발명의 단분자 비대칭 유기 반도체 화합물의 제조방법은 간단한 공정으로 단분자 비대칭 유기 반도체 화합물의 제조가 가능하다.In addition, the method for producing a monomolecular asymmetric organic semiconductor compound of the present invention can produce a monomolecular asymmetric organic semiconductor compound by a simple process.

또한 본 발명의 단분자 비대칭 유기 반도체 화합물을 채용한 유기 반도체 장치는 높은 개방전압과 높은 전하이동도를 가져 효율이 매우 우수하다.Further, the organic semiconductor device employing the monomolecular asymmetric organic semiconductor compound of the present invention has a high open-circuit voltage and a high charge mobility, so that the efficiency is excellent.

본 발명은 하기의 실시예에 의하여 보다 명확히 이해될 수 있으며, 하기의 실시예는 본 발명의 예시 목적에 불과하며 발명의 영역을 제한하고자 하는 것은 아니다.The present invention can be more clearly understood by the following examples, and the following examples are merely illustrative of the present invention and are not intended to limit the scope of the invention.

[실시예 1] 8-Hydroxy-8-methylbenzo[1,2- b :4,5- b' ]dithiophen-4-one의 합성 Example 1 Synthesis of 8-Hydroxy-8-methylbenzo [1,2- b : 4,5- b ' ] dithiophen-4-one

Figure 112014047294971-pat00025
Figure 112014047294971-pat00025

700 ml의 무수 톨루엔이 들어있는 1000 ml 플라스크에 아르곤 분위기에서 benzo[1,2-b:4,5-b′]dithiophene-4,8-dione 4.4 g (20 mmol)을 넣고 상온에서 1시간 교반 후 0 oC로 온도를 낮추었다. 3M methyl magnesium bromide 7 ml (21 mmol)을 30분 동안 적가하였다. 반응 혼합물을 상온에서 하룻밤동안 교반한 후 1N HCl 10 ml로 반응 종결시켰다. Diethyl ether로 3회 추출한 후, MgSO4로 물을 제거한 이후 용매를 제거하였다. 잔류물을 ethyl acetate:diethyl ether(1:1) 혼합용매 50 ml에 녹인 후 필터하여, 필터된 부분을 용매 제거 후 진공 건조하여 4.13 g의 갈색 고체인 표제 화합물을 얻었다(수율 87.5%). 합성된 고체는 더 이상의 정제 없이 다음 단계의 반응에 사용하였다.
Benzo [1,2- b : 4,5- b '] dithiophene-4,8-dione 4.4 g (20 mmol) was added to a 1000 ml flask containing 700 ml of anhydrous toluene and stirred at room temperature for 1 hour The temperature was then lowered to 0 ° C. 7 ml (21 mmol) of 3M methyl magnesium bromide was added dropwise over 30 minutes. The reaction mixture was stirred at room temperature overnight and then quenched with 10 ml of 1N HCl. After three times extraction with diethyl ether, water was removed with MgSO 4 and the solvent was removed. The residue was dissolved in 50 ml of a mixed solvent of ethyl acetate: diethyl ether (1: 1) and filtered. The solvent was removed from the filtrate and vacuum dried to obtain 4.13 g of the title compound (yield 87.5%) as a brown solid. The synthesized solid was used in the next step without further purification.

[실시예 2] 4-(2-ethylhexyloxy)-8-methylbenzo[1,2- b :4,5- b' ]dithiophene의 합성 Example 2 Synthesis of 4- (2-ethylhexyloxy) -8-methylbenzo [1,2- b : 4,5- b ' ] dithiophene

Figure 112014047294971-pat00026
Figure 112014047294971-pat00026

실시예 1에서 합성한 8-Hydroxy-8-methylbenzo[1,2-b:4,5-b']dithiophen-4-one 3.67 g (15.5 mmol)과 zinc dust 2.0 g (31.1 mmol)이 들어있는 250 ml 플라스크에 2M NaOH 용액을 80 ml 넣고 1시간 동안 환류 시켰다. 이후 2-ethylhexyl bromide 6 g (31.1 mmol)과 촉매량의 tetrabutylammonium bromide (0.5 g, 1.6 mmol)을 넣고 6시간 동안 환류 시킨 다음, 반응 혼합물을 150 ml의 차가운 NH4Cl 용액에 붇고, CH2Cl2 100 ml로 3회 추출하였다. 유기 추출 용액을 Na2SO4로 물기를 제거한 이후 회전 증발기를 사용하여 용매를 제거하고, CH2Cl2:헥산 (1:8) 용매를 이동상으로 사용한 실리카겔 컬럼 크로마토그래피를 통하여 3.05 g (수율 59%)의 4-(2-ethylhexyloxy)-8-methylbenzo[1,2-b:4,5-b']dithiophene을 연노란 오일로 얻었다.Containing 3.67 g (15.5 mmol) of 8-Hydroxy-8-methylbenzo [1,2- b : 4,5- b ' ] dithiophen-4-one synthesized in Example 1 and 2.0 g (31.1 mmol) of zinc dust 80 ml of a 2M NaOH solution was added to a 250 ml flask, and the mixture was refluxed for 1 hour. After 2-ethylhexyl bromide 6 g (31.1 mmol) and into the tetrabutylammonium bromide (0.5 g, 1.6 mmol ) a catalytic amount of swelling, and the reaction mixture was refluxed for 6 hours in the cold NH 4 Cl solution of 150 ml, CH 2 Cl 2 And extracted three times with 100 ml. The organic extracts were washed with Na 2 SO 4 , then the solvent was removed using a rotary evaporator and the residue was purified by silica gel column chromatography using a CH 2 Cl 2 : hexane (1: 8) solvent as mobile phase to give 3.05 g %) Of 4- (2-ethylhexyloxy) -8-methylbenzo [1,2- b : 4,5- b ' ] dithiophene as a pale yellow oil.

1H NMR (300 MHz, CDCl3):δ (ppm) 7.51 (1H, d, J=5.5); 7.42 (2H, s); 7.37 (1H, d, J=5.6); 4.19 (2H, d, J=5.5); 2.75 (3H, s); 1.79 (1H, m); 1.59 (4H, m); 1.39 (4H, m); 1.01 (6H, m). 1 H NMR (300 MHz, CDCl 3): δ (ppm) 7.51 (1H, d, J = 5.5); 7.42 (2 H, s); 7.37 (1H, d, J = 5.6); 4.19 (2H, d, J = 5.5); 2.75 (3 H, s); 1.79 (1 H, m); 1.59 (4 H, m); 1.39 (4 H, m); 1.01 (6 H, m).

13C NMR (125MHz, CDCl3):δ(ppm) 147.10; 139.13; 138.22; 129.65; 128.57; 126.54; 125.48; 121.78; 121.00; 120.50; 76.09; 40.74; 30.51; 29.26; 23.90; 23.16; 17.72; 14.19; 11.35. 13 C NMR (125 MHz, CDCl 3 ):? (Ppm) 147.10; 139.13; 138.22; 129.65; 128.57; 126.54; 125.48; 121.78; 121.00; 120.50; 76.09; 40.74; 30.51; 29.26; 23.90; 23.16; 17.72; 14.19; 11.35.

MS(EI): Calcd,332.1; found(M+1)+ 333.
MS (EI): Calcd, 332.1; found (M + l) + 333.

[실시예 3] 8-Hydroxy-8-octylbenzo[1,2- b :4,5- b' ]dithiophen-4-one의 합성 Example 3 Synthesis of 8-Hydroxy-8-octylbenzo [1,2- b : 4,5- b ' ] dithiophen-4-one

Figure 112014047294971-pat00027
Figure 112014047294971-pat00027

700 ml의 무수 톨루엔이 들어있는 1000 ml 플라스크에 아르곤 분위기에서 benzo[1,2-b:4,5-b′]dithiophene-4,8-dione 4.4 g (20 mmol)을 넣고 상온에서 1시간 교반 후 0 oC로 온도를 낮추었다. 1M n-octyl magnesium bromide 21 ml (21 mmol)을 30분 동안 적가하였다. 반응 혼합물을 상온에서 하룻밤동안 교반한 후 1N HCl 10 ml로 반응 종결시켰다. Diethyl ether로 3회 추출한 후, MgSO4로 물을 제거한 이후 용매를 제거하였다. 잔류물을 ethyl acetate:diethyl ether(1:1) 혼합용매 50 ml에 녹인 후 필터하여, 필터된 부분을 용매 제거 후 진공 건조하여 6.60 g의 갈색 고체인 표제 화합물을 얻었다(수율 98.7%). 합성된 고체는 더 이상의 정제 없이 다음 단계의 반응에 사용하였다.
Benzo [1,2- b : 4,5- b '] dithiophene-4,8-dione 4.4 g (20 mmol) was added to a 1000 ml flask containing 700 ml of anhydrous toluene and stirred at room temperature for 1 hour The temperature was then lowered to 0 ° C. 21 ml (21 mmol) of 1M n-octyl magnesium bromide was added dropwise over 30 minutes. The reaction mixture was stirred at room temperature overnight and then quenched with 10 ml of 1N HCl. After three times extraction with diethyl ether, water was removed with MgSO 4 and the solvent was removed. The residue was dissolved in 50 ml of a mixed solvent of ethyl acetate: diethyl ether (1: 1), filtered, and filtered to remove solvent. Vacuum drying was conducted to obtain 6.60 g of the title compound (yield 98.7%) as a brown solid. The synthesized solid was used in the next step without further purification.

[실시예 4] 4-Heptyloxy-8-octylbenzo[1,2- b :4,5- b' ]dithiophene의 합성 Example 4 Synthesis of 4-Heptyloxy-8-octylbenzo [1,2- b : 4,5- b ' ] dithiophene

Figure 112014047294971-pat00028
Figure 112014047294971-pat00028

실시예 3에서 합성한 8-Hydroxy-8-octylbenzo[1,2-b:4,5-b']dithiophen-4-one 3.20 g (9.57 mmol)과 zinc dust 1.24 g (19.1 mmol)이 들어있는 250 ml 플라스크에 2M NaOH 용액을 50 ml 넣고 1시간 동안 환류 시켰다. 이후 n-heptyl bromide 3.4 g (19.1 mmol)과 촉매량의 tetrabutylammonium bromide (0.3 g, 0.96 mmol)을 넣고 6시간 동안 환류 시킨 다음, 반응 혼합물을 150 ml의 차가운 NH4Cl 용액에 붇고, CH2Cl2 70 ml로 3회 추출하였다. 유기 추출 용액을 Na2SO4로 물기를 제거한 이후 회전 증발기를 사용하여 용매를 제거하고, CH2Cl2:헥산 (1:8) 용매를 이동상으로 사용한 실리카겔 컬럼 크로마토그래피를 통하여 3.24 g (수율 81%)의 4-heptyloxy-8-octylbenzo[1,2-b:4,5-b']dithiophene을 연노란 오일로 얻었다.Containing 3.20 g (9.57 mmol) of 8-hydroxy-8-octylbenzo [1,2- b : 4,5- b ' ] dithiophen-4-one synthesized in Example 3 and 1.24 g (19.1 mmol) of zinc dust 50 ml of 2M NaOH solution was added to a 250 ml flask, and the mixture was refluxed for 1 hour. Since n-heptyl bromide 3.4 g (19.1 mmol) and into the tetrabutylammonium bromide (0.3 g, 0.96 mmol ) a catalytic amount of swelling, and the reaction mixture was refluxed for 6 hours in the cold NH 4 Cl solution of 150 ml, CH 2 Cl 2 And extracted three times with 70 ml. The organic extracts were washed with Na 2 SO 4 , then the solvent was removed using a rotary evaporator and the residue was purified by silica gel column chromatography using CH 2 Cl 2 : hexane (1: 8) as a mobile phase to give 3.24 g (Yield 81 %) Of 4-heptyloxy-8-octylbenzo [1,2- b : 4,5- b ' ] dithiophene as a pale yellow oil.

1H NMR (500 MHz, CDCl3): δ(ppm) 7.51(1H, d, J=5.8); 7.43(2H, s); 7.38(1H, d, J=5.6); 4.30(2H, t, J=6.5); 3.14(2H, t, J=7.8); 1.88(2H, m); 1.79(2H, m); 1.59(2H, m); 1.33 (16H, m); 0.89 (6H, m). 1 H NMR (500 MHz, CDCl 3 ):? (Ppm) 7.51 (1H, doublet, J = 5.8); 7.43 (2 H, s); 7.38 (1H, d, J = 5.6); 4.30 (2H, t, J = 6.5); 3.14 (2H, t, J = 7.8); 1.88 (2 H, m); 1.79 (2 H, m); 1.59 (2 H, m); 1.33 (16 H, m); 0.89 (6 H, m).

13C NMR (125MHz, CDCl3): δ(ppm) 146.88; 138.67; 137.75; 130.06; 129.02; 126.61; 126.48; 125.37; 121.78; 120.41; 73.94; 33.19; 31.92; 31.87; 30.61; 29.96; 29.67; 29.50; 29.27; 29.17; 26.07; 22.69; 22.66; 14.14. 13 C NMR (125 MHz, CDCl 3 ):? (Ppm) 146.88; 138.67; 137.75; 130.06; 129.02; 126.61; 126.48; 125.37; 121.78; 120.41; 73.94; 33.19; 31.92; 31.87; 30.61; 29.96; 29.67; 29.50; 29.27; 29.17; 26.07; 22.69; 22.66; 14.14.

MS(EI): Calcd,416.2; found(M+1)+ 417.
MS (EI): Calcd, 416.2; found (M + 1) < + >

[실시예 5] 4-Octyl-8-octyloxybenzo[1,2- b :4,5- b' ]dithiophene의 합성 Example 5 Synthesis of 4-Octyl-8-octyloxybenzo [1,2- b : 4,5- b ' ] dithiophene

Figure 112014047294971-pat00029
Figure 112014047294971-pat00029

실시예 3에서 합성한 8-Hydroxy-8-octylbenzo[1,2-b:4,5-b']dithiophen-4-one 7.21 g (21.55 mmol)과 zinc dust 2.80 g (43.1 mmol)이 들어있는 250 ml 플라스크에 2M NaOH 용액을 120 ml 넣고 1시간 동안 환류 시켰다. 이후 n-octyl bromide 8.32 g (43.1 mmol)과 촉매량의 tetrabutylammonium bromide (0.7 g, 2.16 mmol)을 넣고 6시간 동안 환류 시킨 다음, 반응 혼합물을 150 ml의 차가운 NH4Cl 용액에 붇고, CH2Cl2 100 ml로 3회 추출하였다. 유기 추출 용액을 Na2SO4로 물기를 제거한 이후 회전 증발기를 사용하여 용매를 제거하고, CH2Cl2:헥산 (1:8) 용매를 이동상으로 사용한 실리카겔 컬럼 크로마토그래피를 통하여 6.70 g (수율 72%)의 4-octyl-8-octyloxybenzo[1,2-b:4,5-b']dithiophene을 연노란 오일로 얻었다.Containing 7.21 g (21.55 mmol) of 8-hydroxy-8-octylbenzo [1,2- b : 4,5- b ' ] dithiophen-4-one synthesized in Example 3 and 2.80 g (43.1 mmol) of zinc dust 120 ml of 2M NaOH solution was added to a 250 ml flask, and the mixture was refluxed for 1 hour. Since n-octyl bromide 8.32 g (43.1 mmol) and into the tetrabutylammonium bromide (0.7 g, 2.16 mmol ) a catalytic amount of swelling, and the reaction mixture was refluxed for 6 hours in the cold NH 4 Cl solution of 150 ml, CH 2 Cl 2 And extracted three times with 100 ml. The organic extract was washed with Na 2 SO 4 , then the solvent was removed using a rotary evaporator, and 6.70 g (yield 72%) was obtained through silica gel column chromatography using a CH 2 Cl 2 : hexane (1: 8) %) Of 4-octyl-8-octyloxybenzo [1,2- b : 4,5- b ' ] dithiophene as a pale yellow oil.

1H NMR (300 MHz, CDCl3):δ (ppm) 7.50 (1H, d, J=5.6); 7.43 (2H, s); 7.37 (1H, d, J=5.6); 4.30 (2H, t, J=6.8); 3.14 (2H, t, J=7.6); 1.88 (2H, m); 1.79 (2H, m); 1.56 (2H, m); 1.30 (18H, m); 0.88 (6H, m). 1 H NMR (300 MHz, CDCl 3 ):? (Ppm) 7.50 (1H, doublet, J = 5.6); 7.43 (2 H, s); 7.37 (1H, d, J = 5.6); 4.30 (2H, t, J = 6.8); 3.14 (2H, t, J = 7.6); 1.88 (2 H, m); 1.79 (2 H, m); 1.56 (2 H, m); 1.30 (18H, m); 0.88 (6 H, m).

13C NMR (125MHz, CDCl3): δ(ppm) 146.89; 138.67; 137.76; 130.06; 129.01; 126.60; 126.47; 125.35; 121.77; 120.41; 73.93; 33.19; 31.92; 31.86; 30.61; 29.96; 29.67; 29.50; 29.45; 29.31; 29.27; 26.11; 22.69; 14.13. 13 C NMR (125MHz, CDCl 3 ): δ (ppm) 146.89; 138.67; 137.76; 130.06; 129.01; 126.60; 126.47; 125.35; 121.77; 120.41; 73.93; 33.19; 31.92; 31.86; 30.61; 29.96; 29.67; 29.50; 29.45; 29.31; 29.27; 26.11; 22.69; 14.13.

MS(EI): Calcd,430.2; found(M+1)+ 431.3.
MS (EI): Calcd, 430.2; found (M + 1) < + & gt ; 431.3.

[실시예 6] 4-(2-ethylhexyl)-8-octyloxybenzo[1,2- b :4,5- b' ]dithiophene의 합성 Example 6 Synthesis of 4- (2-ethylhexyl) -8-octyloxybenzo [1,2- b : 4,5- b ' ] dithiophene

Figure 112014047294971-pat00030
Figure 112014047294971-pat00030

실시예 3에서 합성한 8-Hydroxy-8-octylbenzo[1,2-b:4,5-b']dithiophen-4-one 3.2 g (9.57 mmol)과 zinc dust 1.24 g (19.13 mmol)이 들어있는 250 ml 플라스크에 2M NaOH 용액을 60 ml 넣고 1시간 동안 환류 시켰다. 이후 2-ethylhexylbromide 3.7 g 19.13 mmol)과 촉매량의 tetrabutylammonium bromide (0.31 g, 0.96 mmol)을 넣고 6시간 동안 환류 시킨 다음, 반응 혼합물을 100 ml의 차가운 NH4Cl 용액에 붇고, CH2Cl2 50 ml로 3회 추출하였다. 유기 추출 용액을 Na2SO4로 물기를 제거한 이후 회전 증발기를 사용하여 용매를 제거하고, CH2Cl2:헥산 (1:8) 용매를 이동상으로 사용한 실리카겔 컬럼 크로마토그래피를 통하여 3.4 g (수율 82%)의 4-(2-ethylhexyl)-8-octyloxybenzo[1,2-b:4,5-b']dithiophene을 연노란 오일로 얻었다.Containing 3.2 g (9.57 mmol) of 8-hydroxy-8-octylbenzo [1,2- b : 4,5- b ' ] dithiophen-4-one synthesized in Example 3 and 1.24 g (19.13 mmol) of zinc dust 60 ml of a 2M NaOH solution was added to a 250 ml flask, and the mixture was refluxed for 1 hour. Then 3.7 g (19.13 mmol) of 2-ethylhexylbromide and a catalytic amount of tetrabutylammonium bromide (0.31 g, 0.96 mmol) were added and the mixture was refluxed for 6 hours. The reaction mixture was poured into 100 ml of cold NH 4 Cl solution and 50 ml of CH 2 Cl 2 . The organic extract was washed with Na 2 SO 4 , then the solvent was removed using a rotary evaporator, and the residue was purified by silica gel column chromatography using a CH 2 Cl 2 : hexane (1: 8) solvent as a mobile phase to obtain 3.4 g %) Of 4- (2-ethylhexyl) -8-octyloxybenzo [1,2- b : 4,5- b ' ] dithiophene as a pale yellow oil.

1H NMR (500 MHz, CDCl3): δ(ppm) 7.52( 1H, d, J=5.6); 7.44 (2H, dd, J1=1.8, J2=5.6); 7.37 (1H, d, J=5.6); 4.20 (2H, m); 3.15 (2H, t, J=7.7); 1.85 (3H, m); 1.70 (4H, m); 1.62-1.30 (14H, m); 1.03 (3H, t, J=7.4); 0.95(3H, t, J=7.2); 0.89 (3H, t, J=7.2). 1 H NMR (500 MHz, CDCl 3): δ (ppm) 7.52 (1H, d, J = 5.6); 7.44 (2H, dd, J 1 = 1.8, J 2 = 5.6); 7.37 (1H, d, J = 5.6); 4.20 (2 H, m); 3.15 (2H, t, J = 7.7); 1.85 (3H, m); 1.70 (4H, m); 1.62-1.30 (14 H, m); 1.03 (3H, t, J = 7.4); 0.95 (3H, t, J = 7.2); 0.89 (3H, t, J = 7.2).

13C NMR (125MHz, CDCl3): δ(ppm) 147.11; 138.72; 137.81; 129.88; 128.75; 126.47; 125.30; 121.77; 120.38; 76.01; 40.73; 33.19; 31.94; 30.49; 29.96; 29.75; 29.69; 29.52; 29.30; 29.24; 23.89; 23.16; 22.71; 14.89; 14.15; 11.34. 13 C NMR (125 MHz, CDCl 3 ):? (Ppm) 147.11; 138.72; 137.81; 129.88; 128.75; 126.47; 125.30; 121.77; 120.38; 76.01; 40.73; 33.19; 31.94; 30.49; 29.96; 29.75; 29.69; 29.52; 29.30; 29.24; 23.89; 23.16; 22.71; 14.89; 14.15; 11.34.

MS(EI): Calcd,430.2; found(M+1)+ 431.
MS (EI): Calcd, 430.2; found (M + 1) < + & gt ; 431.

[실시예 7] 8-Decyl-8-hydroxybenzo[1,2-:4,5-′]dithiophen-4-one의 합성Example 7 Synthesis of 8-Decyl-8-hydroxybenzo [1,2-: 4,5 - '] dithiophen-4-one

Figure 112014047294971-pat00031
Figure 112014047294971-pat00031

700 ml의 무수 톨루엔이 들어있는 500 ml 플라스크에 알곤 분위기에서 benzo[1,2-b:4,5-b′]dithiophene-4,8-dione 3.3 g (20 mmol)을 넣고 상온에서 1시간 교반 후 0 oC로 온도를 낮추었다. 1M n-decyl magnesium bromide 16.5 ml (16.5 mmol)을 30분 동안 적가한다. 반응 혼합물을 상온에서 하룻밤동안 교반한 후 1N HCl 10 ml로 반응 종결시켰다. Diethyl ether로 3회 추출한 후, MgSO4로 물을 제거한 이후 용매를 제거하였다. 잔류물을 diethyl ether 용매 50 ml에 녹인 후 필터하여, 필터된 부분을 용매 제거 후 진공 건조하여 5.1 g의 갈색 오일을 얻었다(수율 93.6%). 합성된 화합물은 더 이상의 정제 없이 다음 단계의 반응에 사용하였다.
Benzo [1,2- b : 4,5- b '] dithiophene-4,8-dione (3.3 g, 20 mmol) was added to a 500 ml flask containing 700 ml of anhydrous toluene and stirred at room temperature for 1 hour The temperature was then lowered to 0 ° C. 16.5 ml (16.5 mmol) of 1M n-decyl magnesium bromide is added dropwise over 30 minutes. The reaction mixture was stirred at room temperature overnight and then quenched with 10 ml of 1N HCl. After three times extraction with diethyl ether, water was removed with MgSO 4 and the solvent was removed. The residue was dissolved in 50 ml of diethyl ether solvent and filtered. The solvent was removed from the filtrate and vacuum dried to obtain 5.1 g of a brown oil (yield: 93.6%). The synthesized compound was used in the next step without further purification.

[실시예 8] 4-Decyl-8-decyloxybenzo[1,2-:4,5-′]dithiophene의 합성Example 8 Synthesis of 4-Decyl-8-decyloxybenzo [1,2-: 4,5 - '] dithiophene

Figure 112014047294971-pat00032
Figure 112014047294971-pat00032

실시예 7에서 합성한 8-Decyl-8-hydroxybenzo[1,2-:4,5-′]dithiophen-4-one 5.59 g (15.4 mmol)과 zinc dust 2.0 g (30.8 mmol)이 들어있는 250 ml 플라스크에 2M NaOH 용액을 90 ml 넣고 1시간 동안 환류 시켰다. 이후 n-octyl bromide 6.82 g (30.8 mmol)과 촉매량의 tetrabutylammonium bromide (0.5 g, 1.5 mmol)을 넣고 6시간 동안 환류 시킨 다음, 반응 혼합물을 150 ml의 차가운 NH4Cl 용액에 붇고, CH2Cl2 100 ml로 3회 추출하였다. 유기 추출 용액을 Na2SO4로 물기를 제거한 이후 회전 증발기를 사용하여 용매를 제거하고, CH2Cl2:헥산 (1:8) 용매를 이동상으로 사용한 실리카겔 컬럼 크로마토그래피를 통하여 4.6 g (수율 61%)의 4-Decyl-8-decyloxybenzo[1,2-:4,5-′]dithiophene을 연노란 오일로 얻었다.250 ml containing 5.59 g (15.4 mmol) of 8-decyl-8-hydroxybenzo [1,2-: 4,5- '] dithiophen-4-one synthesized in Example 7 and 2.0 g (30.8 mmol) 90 ml of 2M NaOH solution was added to the flask, and the mixture was refluxed for 1 hour. Since n-octyl bromide 6.82 g (30.8 mmol) and a catalytic amount of tetrabutylammonium bromide (0.5 g, 1.5 mmol ) into the swelling, and the reaction mixture was refluxed for 6 hours in the cold NH 4 Cl solution of 150 ml, CH 2 Cl 2 And extracted three times with 100 ml. The organic extract was washed with Na 2 SO 4 , then the solvent was removed using a rotary evaporator, and the residue was purified by silica gel column chromatography using a CH 2 Cl 2 : hexane (1: 8) solvent as mobile phase to obtain 4.6 g %) Of 4-Decyl-8-decyloxybenzo [1,2-: 4,5 - '] dithiophene as a pale yellow oil.

1H NMR (300 MHz, CDCl3):δ (ppm) 7.50 (1H, d, J=5.2); 7.43 (2H, s); 7.36 (1H, d, J=5.5); 4.29 (2H, t, J=6.6); 3.14 (2H, t, J=7.7); 1.87 (2H, m); 1.78 (2H, m); 1.54 (2H, m); 1.26 (26H, broad); 0.88 (6H, m). 1 H NMR (300 MHz, CDCl 3): δ (ppm) 7.50 (1H, d, J = 5.2); 7.43 (2 H, s); 7.36 (1H, d, J = 5.5); 4.29 (2H, t, J = 6.6); 3.14 (2H, t, J = 7.7); 1.87 (2 H, m); 1.78 (2 H, m); 1.54 (2 H, m); 1.26 (26H, broad); 0.88 (6 H, m).

MS(EI): Calcd, 486.3; found(M+1)+ 487.
MS (EI): Calcd, 486.3; found (M + 1) < + >

[실시예 9] 2,6-Bis(trimethyltin)-4-decyl-8-decyloxybenzo[1,2- b :4,5- b' ]dithiophene의 합성 Example 9 Synthesis of 2,6-Bis (trimethyltin) -4-decyl-8-decyloxybenzo [1,2- b : 4,5- b ' ] dithiophene

Figure 112014047294971-pat00033
Figure 112014047294971-pat00033

실시예 8에서 합성한 4-Decyl-8-decyloxybenzo[1,2-:4,5-′]dithiophene 4.6 g (9.45 mmol)을 아르곤 분위기에서 200 ml의 무수 THF에 녹인 후, -78 oC로 냉각한 후 1.6 M n-BuLi 13.0 ml (20.8 mmol)을 30분 동안 적가하였다. 같은 온도에서 30분 동안 교반시킨 후 30분 동안 서서히 상온으로 온도를 올려준 후, 다시 -78 oC로 냉각하고, THF용매에 녹아있는 1 M trimentyltin chloride 20.8 ml 20.8 mmol)을 첨가하였다. 반응 용액을 서서히 상온으로 올리고 하룻밤 동안 교반시켰다. 30 ml의 차가운 물을 첨가하여 반응을 종결시키고, diethyl ether로 3번 추출하였다. 유기 추출물을 물로 2번 씻어준 후, Na2SO4로 물기를 제거한 후 용매를 진공에서 제거하고, 에탄올에서 재결정하여 4.1 g (53%)의 무색 바늘 모양의 결정을 얻었다. Embodiment a 4-Decyl-8-decyloxybenzo synthesized in Example 8: After the [1,2- 4,5 '] dithiophene 4.6 g (9.45 mmol) dissolved in anhydrous THF in a 200 ml argon atmosphere, to -78 o C After cooling, 13.0 ml (20.8 mmol) of 1.6 M n-BuLi was added dropwise over 30 minutes. After stirring at the same temperature for 30 minutes, the temperature was gradually raised to room temperature for 30 minutes. After cooling to -78 ° C again, 20.8 mmol of 1 M trimentyltin chloride dissolved in THF was added. The reaction solution was slowly warmed to room temperature and stirred overnight. The reaction was terminated by the addition of 30 ml of cold water and extracted three times with diethyl ether. The organic extracts were washed twice with water, the water was removed with Na 2 SO 4 , the solvent was removed in vacuo and recrystallized from ethanol to obtain 4.1 g (53%) of colorless needle-like crystals.

1H NMR (300 MHz, CDCl3): δ(ppm) 7.55 (1H, t, J=14.3); 7.45 (1H, t, J=14.5); 4.31 (2H, t, J=6.7): 3.17 (2H, t, J=7.7); 1.84 (4H, m); 1.58 (2H, m); 1.27 (26H, broad); 0.88 (6H, m); 0.44 (18H, m). 1 H NMR (300 MHz, CDCl 3): δ (ppm) 7.55 (1H, t, J = 14.3); 7.45 (1H, t, J = 14.5); 4.31 (2H, t, J = 6.7): 3.17 (2H, t, J = 7.7); 1.84 (4 H, m); 1.58 (2 H, m); 1.27 (26 H, broad); 0.88 (6 H, m); 0.44 (18H, m).

13C NMR (125 MHz, CDCl3): δ(ppm) 145.50; 143.04; 140.75; 139.82; 138.99; 132.78; 131.14; 129.55; 128.23; 125.14; 73.59; 33.25; 31.95; 30.61; 29.94; 29.73; 29.68; 29.64; 29.53; 29.51; 29.39; 26.15; 22.71; 14.14; -8.29; -8.32.
13 C NMR (125 MHz, CDCl 3): δ (ppm) 145.50; 143.04; 140.75; 139.82; 138.99; 132.78; 131.14; 129.55; 128.23; 125.14; 73.59; 33.25; 31.95; 30.61; 29.94; 29.73; 29.68; 29.64; 29.53; 29.51; 29.39; 26.15; 22.71; 14.14; -8.29; -8.32.

[실시예 10] 4,8-dihydrobenzo[1,2-b:4,5-b']dithiophene-4-hydroxy-4-[2-(2-ethylhexyl)thiophen]-8-one의 합성Example 10 Synthesis of 4,8-dihydrobenzo [1,2-b: 4,5-b '] dithiophene-4-hydroxy-4- [2- (2-ethylhexyl) thiophen] -8-one

Figure 112014047294971-pat00034
Figure 112014047294971-pat00034

1.170 g (48.0 mmol)의 마그네슘 금속과 30 ml의 무수 THF를 플라스크에 넣고, 상온에서 결렬하게 교반시켰다. 2-Bromo-5-(2-ethylhexyl)thiophene 6.61 g (24.0 mmol)을 적가한 뒤, 5 시간동안 환류시켰다. 다른 플라스크에 benzo[1,2-b:4,5-b′]dithiophene-4,8-dione 4.41 g (20.0 mmol)과 650 ml의 무수 톨루엔이 들어있는 플라스크를 상온에서 1시간 교반 후 0 oC로 온도를 낮추었다. 합성된 (5-(2-ethylhexyl)thiophene-2-yl)magnesium bromide를 2-bromo-5-(2-ethylhexyl)thiophene 톨루엔 용액에 천천히 적가한 후 반응 혼합물을 상온에서 하룻밤동안 교반시킨 후 5% HCl 15 ml로 반응 종결시켰다. Diethyl ether로 3회 추출한 후, MgSO4로 물을 제거한 이후 용매를 제거하였다. 잔류물을 diethyl ether 용매에 녹인 후 필터하여, 필터된 부분을 용매 제거 후 진공 건조하여 8.13 g의 갈색 고체을 얻었다 (수율 97.6%). 합성된 화합물은 더 이상의 정제 없이 다음 단계의 반응에 사용하였다.1.170 g (48.0 mmol) of magnesium metal and 30 ml of anhydrous THF were added to the flask and stirred at room temperature. 6.61 g (24.0 mmol) of 2-bromo-5- (2-ethylhexyl) thiophene was added dropwise and the mixture was refluxed for 5 hours. In another flask, benzo [1,2- b: 4,5- b ' ] dithiophene-4,8-dione 4.41 g (20.0 mmol) and then stirred for one hour the flask containing dry toluene at room temperature 650 ml of 0 o C to lower the temperature. The reaction mixture was stirred at room temperature overnight, and then a solution of 5% (2-ethylhexyl) thiophene-2-yl magnesium bromide was slowly added dropwise to 2-bromo-5- (2-ethylhexyl) thiophene toluene. The reaction was terminated with 15 ml of HCl. After three times extraction with diethyl ether, water was removed with MgSO 4 and the solvent was removed. The residue was dissolved in a diethyl ether solvent and filtered. The solvent was removed from the filtered portion and vacuum dried to obtain 8.13 g of a brown solid (yield: 97.6%). The synthesized compound was used in the next step without further purification.

1H NMR (CDCl3, 300MHz, δppm): 7.50(d,1H), 7.36(d,1H), 7.34(d,1H), 7.32(d,1H), 6.52(m,2H), 3.17(s,1H), 2.66(d,2H), 1.30-1.25(m,9H), 0.88-0.83(m,6H).
1 H NMR (CDCl 3, 300MHz , δppm): 7.50 (d, 1H), 7.36 (d, 1H), 7.34 (d, 1H), 7.32 (d, 1H), 6.52 (m, 2H), 3.17 (s , 2.66 (d, 2H), 1.30-1.25 (m, 9H), 0.88-0.83 (m, 6H).

[실시예 11] 2,6- 4-[2-(2-ethylhexyl)thiophen-5-yl]-8-octyloxy benzo[1,2-b;3,4-b]dithiophene의 합성Example 11 Synthesis of 2,6- 4- [2- (2-ethylhexyl) thiophen-5-yl] -8-octyloxy benzo [1,2- b; 3,4-b] dithiophene

Figure 112014047294971-pat00035
Figure 112014047294971-pat00035

실시예 10에서 합성한 4,8-dihydrobenzo[1,2-b:4,5-b']dithiophene-4-hydroxy-4-[2-(2-ethylhexyl)thiophen]-8-one 8.13 g (19.5 mmol)과 zinc dust 2.54 g (39 mmol)이 들어있는 250 ml 플라스크에 2M NaOH 용액을 100 ml 넣고 2시간 동안 환류 시켰다. 이후 n-octyl bromide 7.54 g (39 mmol)과 촉매량의 tetrabutylammonium bromide (0.7 g, 2.16 mmol)을 넣고 6시간 동안 환류 시킨 다음, 반응 혼합물에 NH4Cl 용액 50 ml를 떨어뜨려 반응을 종결하고, diethyl ether로 추출하였다. 유기 추출 용액을 무수 MgSO4로 물기를 제거한 이후 회전 증발기를 사용하여 용매를 제거하고, CH2Cl2:헥산 (1:9) 용매를 이동상으로 사용한 실리카겔 컬럼 크로마토그래피를 통하여 7.07 g (수율 70.6%)의 2,6- 4-[2-(2-ethylhexyl)thiophen-5-yl]-8-octyloxy benzo[1,2-b;3,4-b]dithiophene을 오렌지색 오일로 얻었다.Dihydrobenzo [1,2-b: 4,5-b '] dithiophene-4-hydroxy-4- 2- (2-ethylhexyl) thiophen-8-one synthesized in Example 10 19.5 mmol) and 2.54 g (39 mmol) of zinc dust were placed in a 250 ml flask, and the mixture was refluxed for 2 hours. Then 7.54 g (39 mmol) of n-octyl bromide and a catalytic amount of tetrabutylammonium bromide (0.7 g, 2.16 mmol) were added and refluxed for 6 hours. Then, 50 ml of NH 4 Cl solution was added to the reaction mixture, ether. The organic extracts were washed with anhydrous MgSO 4 and the solvent was removed using a rotary evaporator. The residue was subjected to silica gel column chromatography using CH 2 Cl 2 : hexane (1: 9) as a mobile phase to give 7.07 g (Yield: 70.6% ) Of 2,6- 4- [2- (2-ethylhexyl) thiophen-5-yl] -8-octyloxy benzo [1,2- b; 3,4-b] dithiophene as an orange oil.

1H NMR (CDCl3, 300MHz, δppm): 7.59(d,1H), 7.54(d,1H), 7.43(d,1H), 7.40(d,1H), 7.22(d,1H), 6.86(d,1H), 4.38(t,2H), 2.83(d,2H), 1.90(t,2H), 1.7-1.58(m,3H), 1.44-1.31(m,16H), 0.96-0.88(m,9H).
1 H NMR (CDCl 3, 300MHz , δppm): 7.59 (d, 1H), 7.54 (d, 1H), 7.43 (d, 1H), 7.40 (d, 1H), 7.22 (d, 1H), 6.86 (d (M, 3H), 1.44-1.31 (m, 16H), 0.96-0.88 (m, 9H) ).

[실시예 12] bis(trimethyltin)-4-[2-(2-ethylhexyl)thiophene-5-yl]-8-octyloxy benzo[1,2-b;3,4-b]dithiophene의 합성 Example 12 Synthesis of bis (trimethyltin) -4- [2- (2-ethylhexyl) thiophene-5-yl] -8-octyloxybenzo [1,2- b; 3,4-b] dithiophene

Figure 112014047294971-pat00036
Figure 112014047294971-pat00036

실시예 11에서 합성한 4-[2-(2-ethylhexyl)thiophene-5-yl]-8-octyloxy benzo[1,2-b;3,4-b]dithiophene 2.57 g (5.01 mmol)을 아르곤 분위기에서 180 ml의 무수 THF에 녹인 후, -78 oC로 냉각한 후 1.6 M n-BuLi 6.9 ml (11.02 mmol)을 30분 동안 적가하였다. 같은 온도에서 30분 동안 저어준 후 30분 동안 서서히 상온으로 온도를 올려준 후, 다시 -78 oC로 냉각하고, THF용매에 녹아있는 1 M trimentyltin chloride 11 ml 11.02 mmol)을 첨가하였다. 반응 용액을 서서히 상온으로 올리고 1 시간 동안 교반하였다. 메탄올을 첨가하여 반응을 종결시키고, diethyl ether로 3번 추출하였다. 유기 추출물을 MgSO4로 물기를 제거한 후 용매를 진공에서 제거하고, 에탄올에서 여러번 씻어주어 2.50 g (59.5%)의 끈적한 오렌지색 오일을 얻었다. 2.57 g (5.01 mmol) of 4- [2- (2-ethylhexyl) thiophene-5-yl] -8-octyloxybenzo [1,2- b; 3,4- b] dithiophene synthesized in Example 11 was dissolved in an argon atmosphere Was dissolved in 180 ml of anhydrous THF, cooled to -78 ° C, and 6.9 ml (11.02 mmol) of 1.6 M n-BuLi was added dropwise over 30 minutes. After stirring for 30 minutes at the same temperature, the temperature was gradually raised to room temperature for 30 minutes. After cooling to -78 ° C again, 11 ml of 1 M trimentyltin chloride dissolved in THF solution (11.02 mmol) was added. The reaction solution was slowly warmed to room temperature and stirred for 1 hour. The reaction was terminated by the addition of methanol and extracted three times with diethyl ether. The organic extracts were dried over MgSO 4 , the solvent was removed in vacuo and washed several times with ethanol to give 2.50 g (59.5%) of a viscous orange oil.

1H NMR (CDCl3, 300MHz, δppm): 7.62(s,1H), 7.57(s,1H), 7.24(d,1H), 6.87(d,1H), 4.40(t,2H), 2.86(d,2H), 1.84(t,2H), 1.93-1.89(m,3H), 1.45-1.22(m,16H), 0.96-0.87(m,9H), 0.42(t,18H).
1 H NMR (CDCl 3, 300MHz , δppm): 7.62 (s, 1H), 7.57 (s, 1H), 7.24 (d, 1H), 6.87 (d, 1H), 4.40 (t, 2H), 2.86 (d 2H), 1.84 (t, 2H), 1.93-1.89 (m, 3H), 1.45-1.22 (m, 16H), 0.96-0.87 (m, 9H), 0.42 (t, 18H).

[실시예 13] 3-[5-(2,2'-bithiophen-5-yl)thiophen-2-yl]-6-(5-bromothiophen-2-yl)-2,5-di(2-ethylhexyl) pyrrolo[3,4-c]pyrrolo-1,4-dione 의 제조 Example 13 Synthesis of 3- [5- (2,2'-bithiophen-5-yl) thiophen-2-yl] -6- (5-bromothiophen- ) pyrrolo [3,4-c] pyrrolo-1,4-dione

Figure 112014047294971-pat00037
Figure 112014047294971-pat00037

3,6-Bis(5-bromothienyl)-2,5-di(2-ethylhexyl) pyrrolo[3,4-c]pyrrolo-1,4-dione 4.02 g (5.89 mmol), 2,2′-bithiophene-5-boronic acid pinacol ester 1.12 g (3.84 mmol)과 15 ml의 1 M sodium carbonate을 100 ml의 톨루엔이 이미 채워져 있는 플라스크에 넣었다. 아르곤 버블을 사용하여 반응 혼합용액 내의 산소를 제거한 후, 아르곤 분위기에서 90℃에서 24시간 반응을 시켰다. 반응 용액을 실리카 필터를 한 뒤, 메탄올에 침전시킨 후 필터하여 고체를 얻었다. 고체를 헥산/클로로폼 1:1 비율의 용매를 이동상으로 사용한 컬럼 크로마토그래피를 통하여 진한 푸른색의 고체를 얻었다. 고체를 다시 메탄올 300 ml에 넣고 교반하고, 초음파 처리를 10분간 한 이후 필터한 뒤, 고체를 진공오븐에서 50℃ 24시간 동안 건조시켜 1.05 g (36%)의 진한 푸른색 고체를 얻었다. 3,4-c] pyrrolo-1,4-dione 4.02 g (5.89 mmol) of 2,2'-bithiophene- 5-boronic acid pinacol ester (1.12 g, 3.84 mmol) and 15 ml of 1 M sodium carbonate were placed in a flask already filled with 100 ml of toluene. After the oxygen in the reaction mixture was removed using an argon bubble, the reaction was carried out in an argon atmosphere at 90 DEG C for 24 hours. The reaction solution was filtered through a silica filter, precipitated in methanol, and filtered to obtain a solid. The solid was subjected to column chromatography using a hexane / chloroform 1: 1 ratio solvent as a mobile phase to give a dark blue solid. The solid was again poured into 300 ml of methanol, stirred, sonicated for 10 minutes and filtered, and then the solid was dried in a vacuum oven at 50 < 0 > C for 24 hours to give 1.05 g (36%) of a dark blue solid.

1H NMR (300 MHz,CDCl3):δ(ppm) 8.96 (d, J = 4.2 Hz, 1H); 8.63 (d, J = 4.1 Hz, 1H); 7.30 (d, J = 4.1 Hz, 1H); 7.28-7.20 (m, 4H); 7.11 (d, J = 3.7 Hz, 1H); 7.05 (dd, J1= 3.6Hz, J2=1.4Hz, 1H); 4.06-3.93 (m, 4H); 1.88 (m, 2H); 1.31 (m, 16H); 0.88 (m, 12H). 1 H NMR (300 MHz, CDCl 3): δ (ppm) 8.96 (d, J = 4.2 Hz, 1H); 8.63 (d, J = 4.1 Hz, 1 H); 7.30 (d, J = 4.1 Hz, 1 H); 7.28-7.20 (m, 4H); 7.11 (d, J = 3.7 Hz, 1 H); 7.05 (dd, J 1 = 3.6Hz , J 2 = 1.4Hz, 1H); 4.06-3.93 (m, 4H); 1.88 (m, 2 H); 1.31 (m, 16H); 0.88 (m, 12 H).

13C NMR (125 MHz, CDCl3): δ(ppm)161.77, 161.41, 142.95, 140.42, 138.55, 138.41, 137.30, 136.76, 135.11, 134.78, 131.50, 128.19, 128.03, 126.06, 125.32, 124.75, 124.41, 118.60, 108.51, 108.10, 46.13, 39.40, 39.26, 30.51, 30.33, 28.70, 28.48, 23.83, 23.73, 23.26, 23.18, 14.23, 14.16, 10.69, 10.64. 13 C NMR (125 MHz, CDCl 3 ):? (Ppm) 161.77, 161.41, 142.95, 140.42, 138.55, 138.41, 137.30, 136.76, 135.11, 134.78, 131.50, 128.19, 128.03, 126.06, 125.32, 124.75, 124.41, 118.60, 108.51, 108.10, 46.13, 39.40, 39.26, 30.51, 30.33, 28.70, 28.48, 23.83, 23.73, 23.26, 23.18, 14.23, 14.16, 10.69, 10.64.

EI-MS m/z calcd for C38H43BrN2O2S4 (M+):766.14; found:767
EI-MS m / z calcd for C 38 H 43 BrN 2 O 2 S 4 (M + ): 766.14; found: 767

[실시예 14] 2,6-bis{5-{6-[5-(2,2'-bithiophen-5-yl)thiophen-2-yl]-2,5-di(2-ethylhexyl)pyrrolo[3,4-c]pyrrolo-1,4-dione-3-yl}thiophen-2-yl}-4-decyl-8-decyloxybenzo[1,2-b:4,5-′]dithiophene 의 합성 Example 14 Synthesis of 2,6-bis {5- {6- [5- (2,2'-bithiophen-5-yl) thiophen-2-yl] -2,5- di (2- ethylhexyl) pyrrolo [ 3,4-c] pyrrolo-1,4-dione-3-yl} thiophen-2-yl} -4-decyl-8-decyloxybenzo [1,2- b: 4,5- '] dithiophene

Figure 112014047294971-pat00038
Figure 112014047294971-pat00038

20 ml의 플라스크에 2,6-bis(trimethyltin)-4-decyl-8-decyloxybenzo[1,2-b:4,5-b']dithiophene 98 mg (0.12 mmol), 3-[5-(2,2'-bithiophen-5-yl)thiophen-2-yl]-6-(5-bromothiophen-2-yl)-2,5-di(2-ethylhexyl) pyrrolo[3,4-c]pyrrolo-1,4-dione 200 mg (0.26 mmol)과 톨루엔 5 ml, DMF 1 ml를 넣어준 후, 아르곤 버블을 통하여 산소를 제거하였다. 혼합 용액에 tetrakis(triphenylphosphine) palladium(0) 촉매 6 mg (0.005 mmol)를 넣어주고 다시 아르곤 버블을 진행하였다. 반응 용액을 100℃에서 24시간 동안 아르곤 분위기에서 반응을 진행한 후, 반응 용액을 메탄올에 떨어뜨리고 필터하였다. 고체를 헥산/클로로폼 이동상 용매를 1/2 비율에서 1/10 비율로 바꾸어가며 컬럼 크로마토그램을 진행하여 초록색의 고체를 얻었다. 얻어진 고체를 다시 100 ml의 메탄올에 침전시키고 10분동안 초음파 처리를 한 뒤 필터하고, 뜨거운 메탄올, 아세톤, 헥산으로 차례로 씻어준 뒤, 진공 오븐에서 50℃ 24시간 동안 건조시켜 163 mg 73%)의 초록색 고체를 얻었다. A 20 ml flask was charged with 98 mg (0.12 mmol) of 2,6-bis (trimethyltin) -4-decyl-8-decyloxybenzo [1,2- b : 4,5- b ' ] dithiophene, 3- [5- , 2'-bithiophen-5-yl) thiophen-2-yl] -6- (5-bromothiophen-2-yl) -2,5-di (2- ethylhexyl) pyrrolo [3,4- c] pyrrolo- , 4-dione (200 mg, 0.26 mmol), toluene (5 ml) and DMF (1 ml) were added and then the oxygen was removed through an argon bubble. To the mixed solution, 6 mg (0.005 mmol) of tetrakis (triphenylphosphine) palladium (0) catalyst was added, followed by argon bubbling. The reaction solution was reacted in an argon atmosphere at 100 ° C for 24 hours, and then the reaction solution was dropped in methanol and filtered. The column was chromatographed on a hexane / chloroform mobile phase solvent at 1/2 to 1/10 ratio to obtain a green solid. The obtained solid was again precipitated in 100 ml of methanol, sonicated for 10 minutes, filtered, washed with hot methanol, acetone, and hexane sequentially, and then dried in a vacuum oven at 50 ° C for 24 hours to obtain 163 mg of 73% A green solid was obtained.

1H NMR (500 MHz, CDCl3):δ(ppm) 9.01 (4H, broad); 7.39 (1H, s); 7.24 (3H, m); 7.20 (2H, m); 7.13( 4H, m); 7.06 (2H, m); 7.01 (2H, m); 6.97 (2H, m); 4.33 (2H, t, J=7.3); 4.02 (8H, broad); 3.00 (2H, m); 1.94 (6H, m); 1.76 (2H, m); 1.67 (2H, m); 1.45-1.30 (58H, broad); 0.97 (30H, m).
1 H NMR (500 MHz, CDCl 3): δ (ppm) 9.01 (4H, broad); 7.39 (1H, s); 7.24 (3 H, m); 7.20 (2 H, m); 7.13 (4 H, m); 7.06 (2 H, m); 7.01 (2 H, m); 6.97 (2 H, m); 4.33 (2H, t, J = 7.3); 4.02 (8H, broad); 3.00 (2 H, m); 1.94 (6H, m); 1.76 (2 H, m); 1.67 (2 H, m); 1.45-1.30 (58H, broad); 0.97 (30H, m).

[실시예 15] 2,6-bis{5-{6-[5-(2,2'-bithiophen-5-yl)thiophen-2-yl]-2,5-di(2-ethylhexyl)pyrrolo[3,4-c]pyrrolo-1,4-dione-3-yl}thiophen-2-yl}-4-decyl-8-decyloxybenzo[1,2-b:4,5-′]dithiophene 의 합성 Example 15 Preparation of 2,6-bis {5- {6- [5- (2,2'-bithiophen-5-yl) thiophen-2-yl] -2,5- di (2- ethylhexyl) pyrrolo [ 3,4-c] pyrrolo-1,4-dione-3-yl} thiophen-2-yl} -4-decyl-8-decyloxybenzo [1,2- b: 4,5- '] dithiophene

Figure 112014047294971-pat00039
Figure 112014047294971-pat00039

20 ml의 플라스크에 bis(trimethyltin)-4-[2-(2-ethylhexyl)thiophene-5-yl]-8-octyloxy benzo[1,2-b;3,4-b]dithiophene 100 mg (0.12 mmol), 3-[5-(2,2'-bithiophen-5-yl)thiophen-2-yl]-6-(5-bromothiophen-2-yl)-2,5-di(2-ethylhexyl) pyrrolo[3,4-c]pyrrolo-1,4-dione 198 mg (0.26 mmol)과 톨루엔 5 ml, DMF 1 ml를 넣어준 후, 아르곤 버블을 통하여 산소를 제거하였다. 혼합 용액에 tetrakis(triphenylphosphine) palladium(0) 촉매 7 mg (5 mol%)를 넣어주고 다시 아르곤 버블을 진행하였다. 반응 용액을 100℃에서 24시간 동안 아르곤 분위기에서 반응을 진행한 후, 반응 용액을 메탄올에 떨어뜨리고 필터하였다. 고체를 헥산/클로로폼 이동상 용매를 1/2 비율에서 1/10 비율로 바꾸어가며 컬럼 크로마토그램을 진행하여 초록색의 고체를 얻었다. 얻어진 고체를 다시 100 ml의 메탄올에 침전시키고 10분동안 초음파 처리를 한 뒤 필터하고, 뜨거운 메탄올, 아세톤, 헥산으로 차례로 씻어준 뒤, 진공 오븐에서 50℃ 24시간 동안 건조시켜 185 mg 82%)의 초록색 고체를 얻었다.To a 20 ml flask was added 100 mg (0.12 mmol) of bis (trimethyltin) -4- [2- (2-ethylhexyl) thiophene-5-yl] -8-octyloxy benzo [1,2- b; 3,4- b] dithiophene ), 3- [5- (2,2'-bithiophen-5-yl) thiophen-2-yl] -6- (5-bromothiophen- 3,4-c] pyrrolo-1,4-dione (198 mg, 0.26 mmol), toluene (5 ml), and DMF (1 ml) were purged with argon bubbles. To the mixed solution, 7 mg (5 mol%) of tetrakis (triphenylphosphine) palladium (0) catalyst was added and then argon bubbling was conducted again. The reaction solution was reacted in an argon atmosphere at 100 ° C for 24 hours, and then the reaction solution was dropped in methanol and filtered. The column was chromatographed on a hexane / chloroform mobile phase solvent at 1/2 to 1/10 ratio to obtain a green solid. The resulting solid was again precipitated in 100 ml of methanol, sonicated for 10 minutes, filtered, washed with hot methanol, acetone, and then hexane, and then dried in a vacuum oven at 50 ° C for 24 hours to obtain 185 mg of 82% A green solid was obtained.

1H NMR (300 MHz, CDCl3): δ(ppm) 9.01 (4H, broad); 7.43(1H, s); 7.36(1H, d); 7.17-7.13 (4H, m); 7.09-7.06 (4H, m); 6.98-6.88 (8H, m); 4.33 (2H, t, J= 7.3); 4.02 (8H, broad); 3.00 (2H, m); 1.94 (6H, m); 1.76 (2H, m); 1.67 (2H, m); 1.45-1.30 (50H, broad); 0.97 (30H, m).
1 H NMR (300 MHz, CDCl 3 ):? (Ppm) 9.01 (4H, broad); 7.43 (1H, s); 7.36 (1H, d); 7.17-7.13 (4 H, m); 7.09-7.06 (4 H, m); 6.98-6.88 (8 H, m); 4.33 (2H, t, J = 7.3); 4.02 (8H, broad); 3.00 (2 H, m); 1.94 (6H, m); 1.76 (2 H, m); 1.67 (2 H, m); 1.45-1.30 (50H, broad); 0.97 (30H, m).

[실시예 16] (5Z,5'Z)-5,5'-(((4-octyl-8-(octyloxy)benzo[1,2-b:4,5-b']dithiophene-2,6-diyl)bis(3',3'',4-trihexyl-[2,2':5',2''-terthiophene]-5'',5-diyl))bis(methanylylidene))bis(3-ethyl-2-thioxothiazolidin-4-one) (4) 의 제조
Example 16 Synthesis of (5Z, 5'Z) -5,5 '- (((4-octyl-8- (octyloxy) benzo [1,2- b: 4,5- b'] dithiophene- bis (3 ', 3'', 4-trihexyl- [2,2': 5 ', 2''- terthiophene] -5', 5-diyl) bis (methanylidene) ethyl-2-thioxothiazolidin-4-one) (4)

5'',5'''''-(4-octyl-8-(octyloxy)benzo[1,2-b:4,5-b']dithiophene-2,6-diyl)bis(3',3'',4-trihexyl-[2,2':5',2''-terthiophene]-5-carbaldehyde)의 합성 5 '', 5 '' - (4-octyl-8- (octyloxy) benzo [1,2- b: 4,5- b '] dithiophene-2,6- '', 4-trihexyl- [2,2 ': 5', 2 "-terthiophene] -5-carbaldehyde

Figure 112014047294971-pat00040
Figure 112014047294971-pat00040

아르곤가스 존재하에 5''-bromo-,3',3'',4-trihexyl-2,2':5',2''-trithiophene-5-carbaldehyde (250 mg, 0.27 mmol)와 2,6-bis(trimethyl tin)-4,8-bis(octyloxy)benzo[1,2-b:4,5-b']dithiophene(90 mg, 0.12 mmol)를 톨루엔:DMF (10 mL,9:1 v/v)혼합용매에 첨가하고 여기에 Pd(PPh3)4 (15 mg, 0.012 mmol)를 첨가하여 115℃에서 24시간동안 교반시켰다. 반응혼합물을 물(25 mL)을 첨가하고 CH2Cl2로 추출한후 얻어진 유기층을 물로 세척하고 잔류하는 수분을 Na2SO4로 제거한 후 컬럼 크로마토그래피(디클로로메탄:헥산)로 분리정제하여 더 이상 정제없이 다음반응에 사용하였다. 5 ', 5'-trithiophene-5-carbaldehyde (250 mg, 0.27 mmol) and 2,6' -bis (trimethyl tin) -4,8-bis (octyloxy) benzo [1,2- b: 4,5- b '] dithiophene (90 mg, 0.12 mmol) in toluene: DMF (10 mL, 9: 1 v / v) was added to the mixed solvent and the addition of Pd (PPh 3) 4 (15 mg, 0.012 mmol) here it was stirred at 115 ℃ for 24 hours. After the reaction mixture was diluted with water (25 mL) and extracted with CH 2 Cl 2 , the obtained organic layer was washed with water, and the remaining water was removed with Na 2 SO 4 , and the residue was purified by column chromatography (dichloromethane: hexane) The following reaction was used without purification.

Figure 112014047294971-pat00041
Figure 112014047294971-pat00041

화합물 3(170mg,0.10mmol), 3-Ethylrhodanine(82mg,0.5mmol) 및 AcONH4(77mg,1.0mmol)을 클로로벤젠과 아세트산의 혼합용매(1:1v/v) 10mL에 첨가하여 16시간동안 가열환류시켰다. 반응혼합물에 50mL의 메탄올을 첨가하여 3시간동안 교반시킨 후 생성된 고체를 여과하고 잔류물을 메탄올로 세척하였다. 얻어진 고체를 다시 디클로로메탄에 녹여 칼럼크로마토그래피(디클로로메탄:헥산 2:3)으로 분리정제하여 어두운갈색의 고체인 표제화합물 4를 얻었다(142mg,71%yield).To a solution of Compound 3 (170 mg, 0.10 mmol), 3-Ethylrhodanine (82 mg, 0.5 mmol) and AcONH 4 (77 mg, 1.0 mmol) in 10 mL of a mixed solvent of chlorobenzene and acetic acid (1: 1 v / v) Lt; / RTI > 50 mL of methanol was added to the reaction mixture, and the mixture was stirred for 3 hours. The resulting solid was filtered and the residue was washed with methanol. The resulting solid was dissolved again in dichloromethane and the separated and purified by column chromatography (dichloromethane: hexane 2: 3) to give the title compound 4 as a dark brown solid (142 mg, 71% yield).

1HNMR(300MHz,CHCl3):δ 7.93 (s, 2H) 7.46 (s, 1H), 7.37 (s, 1H) 7.13(s, 1H), 7.12 (s, 1H), 7.06 (s, 2H), 7.01 (s, 2H, ), 4.30 (t, J = 6.5 Hz 2H), 4.18 (q, J = 7.2 Hz 4H), 3.07(m, J = 8.2 Hz 2H), 2.82 (m, 12H), 1.92 (m, 2H), 1.69 (m, 15H), 1.29 (m, 61H), 0.890 (m, 24 H).
1 HNMR (300MHz, CHCl 3) : δ 7.93 (s, 2H) 7.46 (s, 1H), 7.37 (s, 1H) 7.13 (s, 1H), 7.12 (s, 1H), 7.06 (s, 2H), J = 7.2 Hz), 3.07 (m, J = 8.2 Hz 2H), 2.82 (m, 12H), 1.92 m, 2H), 1.69 (m, 15H), 1.29 (m, 61H), 0.890 (m, 24H).

[비교예 1] 2,6-Bis(5-(6-([2,2':5',2''-terthiophen]-5-yl)-2,5-bis(2-ethylhexyl)pyrrolo[3,4- c ]pyrrole-1,4-dione-3-yl)thiophen-2-yl)-4,8-bis(octyloxyl)benzo[1,2- b :4,5- b' ]dithiophene의 제조 Comparative Example 1 Preparation of 2,6-Bis (5- (6 - ([2,2 ': 5', 2 "-terthiophen] -5- 3,4- c ] pyrrole-1,4-dione-3-yl) thiophen-2-yl) -4,8-bis (octyloxyl) benzo [1,2- b : 4,5- b ' ] dithiophene Produce

Figure 112014047294971-pat00042
Figure 112014047294971-pat00042

2구 플라스크에 아르곤가스 존재하에 3-([2,2':5',2''-terthiophen]-5-yl)-6-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)pyrrolo[3,4-c]pyrrole-1,4-dione(161mg,0.21mmol)와 2,6-bis(trimethyltin)-4,8-bis(octyloxy)benzo[1,2-b:4,5-b']dithiophene(77 mg, 0.1 mmol)을 첨가하고 여기에 10 mL의 톨루엔과 1 mL의 N,N-dimethylformamide을 첨가하였다. 여기에 tetrakis(triphenylphosphine) palladium(0) (6 mg)을 첨가한 후 110 oC에서 24시간동안 교반시켰다. 반응이 완료되면 메탄올을 첨가하고 여과한 후 칼럼크로마토그래프(클로로포름)로 분리정제하여 진한 초록색의 고체를 얻은 후 100mL의 메탄올에 녹여 10분동안 초음파 처리한 후 여과하였다. 얻어진 고체를 과량의 메탄올로 세척하고 50oC에서 24시간동안 진공하에서 건조하여 진한 초록색 고체인 표제 화합물을 얻었다146mg (80%yield).([2,2 ': 5', 2 "-terthiophen] -5-yl) -6- (5-bromothiophen-2-yl) -2,5-bis 2-ethylhexyl) pyrrolo [3,4- c ] pyrrole-1,4-dione (161mg, 0.21mmol) and 2,6-bis (trimethyltin) -4,8- bis (octyloxy) benzo [1,2- b : 4,5- b '] dithiophene (77 mg, 0.1 mmol) was added thereto, and 10 mL of toluene and 1 mL of N, N-dimethylformamide were added thereto. Tetrakis (triphenylphosphine) palladium (0) (6 mg) was added thereto, followed by stirring at 110 ° C for 24 hours. After completion of the reaction, methanol was added, filtered, and purified by column chromatography (chloroform) to obtain a deep green solid, which was dissolved in 100 mL of methanol, sonicated for 10 minutes, and filtered. The resulting solid was washed with excess methanol and dried under vacuum at 50 ° C for 24 hours to give the title compound as a dark green solid, 146 mg (80% yield).

1H NMR (300 MHz, CDCl3):δ(ppm) 8.98(4H), 7.34(2H), 7.24(2H), 7.20(2H), 7.13(4H), 7.05(2H), 6.98(4H), 4.27(4H), 4.01(8H), 1.94(8H), 1.64(4H), 1.38(48H), 0.94(30H).
1 H NMR (300 MHz, CDCl 3): δ (ppm) 8.98 (4H), 7.34 (2H), 7.24 (2H), 7.20 (2H), 7.13 (4H), 7.05 (2H), 6.98 (4H), 4.27 (4H), 4.01 (8H), 1.94 (8H), 1.64 (4H), 1.38 (48H), 0.94 (30H).

[실시예 17] 유기 광전자소자의 제작[Example 17] Fabrication of organic optoelectronic devices

상기 실시예 14에서 제조된 단분자 유기 반도체 화합물을 전자공여체로 사용하고, C71-PCBM을 전자수용체로 사용하되, 그 배합비를 1:1 중량비로 혼합하여 제조된 광활성층 재료를 1-chloronaphtalene 0.3 부피%를 포함하는 클로로포름 용매에 광활성층 재료가 1.5%의 중량비로 함유되도록 용해시켜 광활성층 용액을 제조하였다.Using a single-molecule organic semiconductor compound prepared in Example 14 as an electron donor and, C 71 -PCBM but the use as an electron acceptor, and the mixing ratio of 1: 1 mixture of the optically active layer material prepared by a 1-chloronaphtalene 0.3 weight ratio The photoactive layer material was dissolved in a chloroform solvent containing a vol% at a weight ratio of 1.5% to prepare a photoactive layer solution.

글로브 박스 내에서 아르곤 분위기 하에서 PEDOT(폴리(3,4-에틸렌디옥시티오펜)층(40~50nm)이 도입된 ITO 유리 기판에 상기에서 제조된 광활성층 용액을 0.45㎛ filter에 filtering을 시킨 후 스핀 코팅(1000rpm/30s)하여 100nm 두께의 광활성층을 도입하여 2시간동안 건조시켰다. 이어서 1 x 10-6torr의 진공도를 가진 진공 챔버에서 칼슘 2 nm(0.1Å/s)와 알루미늄 100㎚(0.1Å/s)을 순차적으로 열증착하여 유기 광전자 소자를 제조하였다. 제작한 유기 광전자 소자는 100 mA/cm2 (AM 1.5G) 조건의 인공광모사 장치에서 J-V 특성을 확인하여 하기 표 1에 그 결과를 나타내었다.
The photoactive layer solution prepared above was filtered through a 0.45 μm filter on an ITO glass substrate into which PEDOT (poly (3,4-ethylenedioxythiophene) layer (40 to 50 nm) was introduced in an argon atmosphere in a glove box, (0.1 Å / s) and 100 nm (0.1 Å / s) of aluminum in a vacuum chamber with a vacuum of 1 × 10 -6 torr, followed by drying for 2 hours. A / s) were successively thermally deposited to fabricate an organic optoelectronic device. The fabricated organic optoelectronic device was confirmed to have JV characteristics in an artificial light simulator under the condition of 100 mA / cm 2 (AM 1.5G) Respectively.

[실시예 18] 유기 광전자소자의 제작 [Example 18] Fabrication of organic optoelectronic device

실시예 17에서 실시예 14에서 제조된 단분자 유기 반도체 화합물 대신 실시예 15에서 제조된 단분자 유기 반도체 화합물을 사용한 것을 제외하고는 실시예 17과 동일한 방법으로 제조하였으며, 제작된 유기 광전자 소자의 특성은 하기 표 1에 나타내었다.
Example 17 was prepared in the same manner as in Example 17, except that the monomolecular organic semiconductor compound prepared in Example 15 was used instead of the monomolecular organic semiconductor compound prepared in Example 14, and the characteristics of the prepared organic optoelectronic device Are shown in Table 1 below.

[실시예 19] 유기 광전자소자의 제작 [Example 19] Fabrication of organic optoelectronic device

실시예 17에서 실시예 14에서 제조된 단분자 유기 반도체 화합물 대신 실시예 16에서 제조된 단분자 유기 반도체 화합물을 사용한 것을 제외하고는 실시예 17과 동일한 방법으로 제조하였으며, 제작된 유기 광전자 소자의 특성은 하기 표 1에 나타내었다.
Example 17 was prepared in the same manner as in Example 17, except that the monomolecular organic semiconductor compound prepared in Example 16 was used in place of the monomolecular organic semiconductor compound prepared in Example 14. The properties of the produced organic optoelectronic device Are shown in Table 1 below.

[비교예 2] 유기 광전자소자의 제작 [Comparative Example 2] Production of organic optoelectronic device

실시예 17에서 실시예 14에서 제조된 단분자 유기 반도체 화합물 대신 비교예 1에서 제조된 단분자 유기 반도체 화합물을 사용한 것을 제외하고는 실시예 17과 동일한 방법으로 제조하였으며, 제작된 유기 광전자 소자의 특성은 하기 표 1에 나타내었다.Example 17 was prepared in the same manner as in Example 17, except that the monomolecular organic semiconductor compound prepared in Comparative Example 1 was used in place of the monomolecular organic semiconductor compound prepared in Example 14. The properties of the prepared organic optoelectronic device Are shown in Table 1 below.

광개발전압
(Voc)
[V]
Light development voltage
(Voc)
[V]
광단락전류밀도 (Jsc)
[mA/cm2]
Short circuit current density (Jsc)
[mA / cm 2 ]
필펙터
(FF)
Phil Fetcher
(FF)
에너지변환효율
[%]
Energy conversion efficiency
[%]
실시예 17Example 17 0.680.68 11.9711.97 0.470.47 3.573.57 실시예 18Example 18 0.610.61 5.365.36 0.530.53 1.711.71 실시예 19Example 19 0.900.90 8.468.46 0.460.46 3.543.54 비교예 2Comparative Example 2 0.630.63 2.392.39 0.450.45 0.900.90

표 1에서 보이는 바와 같이 본 발명의 단분자 유기 반도체 화합물을 함유하는 유기 광전자 소자가 비교예 1의 소자와 대비하여 전류밀도 및 필펙터가 증가하여 효율이 현저하게 향상된 것을 알 수 있다.As shown in Table 1, the organic optoelectronic device containing the monomolecular organic semiconductor compound of the present invention has remarkably improved efficiency due to an increase in the current density and the filter factor as compared with the device of Comparative Example 1. [

대칭적인 치환기를 가지는 비교예의 소자와 대비하여 본 발명의 단분자 유기 반도체 화합물을 포함하는 유기전자 소자의 특성이 향상된 것은 비대칭적인 치환기를 가지는 본 발명의 단분자 유기 반도체 화합물의 구조적인 특징에 기인한 것으로 판단된다. The improvement in the characteristics of the organic electronic device comprising the monomolecular organic semiconductor compound of the present invention in comparison with the device of the comparative example having symmetrical substituents is due to the structural characteristics of the monomolecular organic semiconductor compound of the present invention having an asymmetric substituent .

Claims (10)

삭제delete 삭제delete 삭제delete 삭제delete 하기 화학식 2 또는 3으로 표시되는 것을 특징으로 하는 유기 반도체 화합물.
[화학식 2]
Figure 112016076188663-pat00051

[화학식 3]
Figure 112016076188663-pat00052

[상기 화학식 2 및 3에서,
Z는 S이고;
R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며;
R2는 (C1-C20)알킬이며;
R3 내지 R6 및 R11은 서로 독립적으로 수소 또는 (C1-C20)알킬기이며;
A2, A3, B2 및 B3은 서로 독립적으로 (C3-C20)헤테로아릴렌이며;
R7 또는 R8은 서로 독립적으로 수소 또는
Figure 112016076188663-pat00067
이며;
l, m, p 및 q는 0 내지 3의 정수이고;
R′은 수소 또는 (C1-C20)알킬이며;
상기 R1의 알킬기 또는 헤테로아릴, R2의 알킬, 및 A2 내지 A3 B2 내지 B3의 헤테로아릴렌은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]
(2) or (3).
(2)
Figure 112016076188663-pat00051

(3)
Figure 112016076188663-pat00052

[In the above formulas (2) and (3)
Z is S;
R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl;
R 2 is (C 1 -C 20) alkyl;
R 3 to R 6 and R 11 are independently of each other hydrogen or a (C 1 -C 20) alkyl group;
A 2 , A 3 , B 2 and B 3 are, independently of one another, (C3-C20) heteroarylene;
R 7 or R 8 independently of one another are hydrogen or
Figure 112016076188663-pat00067
;
l, m, p and q are integers of 0 to 3;
R 'is hydrogen or (C1-C20) alkyl;
The R group or a heteroaryl group, the alkyl of R 2 1, and A 2 to A 3, and Heteroarylene of B 2 to B 3 is (C1-C20) alkyl, (C2-C20) alkenyl, (C2-C20) alkynyl, (C1-C20) alkoxy, an amino group, a hydroxyl group, a halogen group, between An amino group, an amino group, an amino group, an amino group, an amino group, an amino group, an amino group, an anion group, a nitro group, a trifluoromethyl group, and a silyl group.
하기 화학식 4로 표시되는 화합물과 하기 화학식 5로 표시되는 화합물을 반응시켜 하기 화학식 1의 유기 반도체 화합물을 제조하는 단계;를 포함하는 유기 반도체 화합물의 제조방법.
[화학식 1]
Figure 112016014610913-pat00054

[화학식 4]
Figure 112016014610913-pat00055

[화학식 5]
Figure 112016014610913-pat00056

[상기 화학식 1, 4 및 5에서,
Z는 S이고;
R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며;
R2는 (C1-C20)알킬이며,
R7 또는 R8은 서로 독립적으로 수소 또는
Figure 112016014610913-pat00068
이며;
R′은 수소 또는 (C1-C20)알킬이며;
A1 내지 A3 및 B1 내지 B3은 서로 독립적으로 (C3-C20)헤테로아릴렌이며,
n 또는 o는 1 내지 3의 정수이고;
l, m, p 및 q는 0 내지 3의 정수이고;
T는 Sn(R51)(R52)(R53)이며, R51 내지 R53 (C1-C10)알킬이며;
X는 할로겐이며;
상기 R1의 알킬기 또는 헤테로아릴, R2의 알킬, 및 A1 내지 A3 B1 내지 B3의 헤테로아릴렌은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]
Reacting a compound represented by the following formula (4) with a compound represented by the following formula (5) to produce an organic semiconductor compound represented by the following formula (1).
[Chemical Formula 1]
Figure 112016014610913-pat00054

[Chemical Formula 4]
Figure 112016014610913-pat00055

[Chemical Formula 5]
Figure 112016014610913-pat00056

[In the above formulas (1), (4) and (5)
Z is S;
R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl;
R 2 is (C 1 -C 20) alkyl,
R 7 or R 8 independently of one another are hydrogen or
Figure 112016014610913-pat00068
;
R 'is hydrogen or (C1-C20) alkyl;
A 1 to A 3 and B 1 to B 3 independently of one another are (C3-C20) heteroarylene,
n or o is an integer from 1 to 3;
l, m, p and q are integers of 0 to 3;
T is Sn (R 51 ) (R 52 ) (R 53 ), R 51 to R 53 are (C1-C10) alkyl;
X is halogen;
The R group or a heteroaryl group, the alkyl of R 2 1, and A 1 to A 3, and The heteroarylene of B 1 to B 3 is selected from the group consisting of (C 1 -C 20) alkyl, (C 2 -C 20) alkenyl, (C 2 -C 20) alkynyl, An amino group, an amino group, an amino group, an amino group, an amino group, an amino group, an amino group, an anion group, a nitro group, a trifluoromethyl group, and a silyl group.
하기 화학식 4로 표시되는 화합물과 하기 화학식 5-1로 표시되는 화합물을 반응시켜 하기 화학식 5-2의 화합물을 제조하고 하기 화학식 5-2의 화합물과 하기 화학식 5-3의 화합물을 반응시켜 하기 화학식 1의 유기 반도체 화합물을 제조하는 단계;를 포함하는 유기 반도체 화합물의 제조방법.
[화학식 1]
Figure 112016014610913-pat00058

[화학식 4]
Figure 112016014610913-pat00059

[화학식 5-1]
Figure 112016014610913-pat00060

[화학식 5-2]
Figure 112016014610913-pat00061

[화학식 5-3]
R7-1-H
[상기 화학식 1, 4, 5-1 내지 5-3에서,
Z는 S이고;
R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며;
R2는 (C1-C20)알킬이며,
R7 또는 R8은 서로 독립적으로
Figure 112016014610913-pat00069
이며;
R′은 수소 또는 (C1-C20)알킬이며;
R7-1
Figure 112016014610913-pat00070
이며;
A1 내지 A3 및 B1 내지 B3은 서로 독립적으로 (C3-C20)헤테로아릴렌이며,
n 또는 o는 1 내지 3의 정수이고;
l, m, p 및 q는 0 내지 3의 정수이고;
T는 Sn(R51)(R52)(R53)이며, R51 내지 R53 (C1-C10)알킬이며;
X는 할로겐이며;
상기 R1의 알킬기 또는 헤테로아릴, R2의 알킬, 및 A1 내지 A3 B1 내지 B3의 헤테로아릴렌은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, (C3-C20)시클로알킬, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]
Reacting a compound represented by the following formula (4) with a compound represented by the following formula (5-1) to prepare a compound represented by the following formula (5-2), reacting the compound represented by the following formula (5-2) 1. A method for producing an organic semiconductor compound, comprising:
[Chemical Formula 1]
Figure 112016014610913-pat00058

[Chemical Formula 4]
Figure 112016014610913-pat00059

[Formula 5-1]
Figure 112016014610913-pat00060

[Formula 5-2]
Figure 112016014610913-pat00061

[Formula 5-3]
R 7-1 -H
[In the formulas (1), (4) and (5-1) to (5-3)
Z is S;
R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl;
R 2 is (C 1 -C 20) alkyl,
R 7 or R 8 independently of one another
Figure 112016014610913-pat00069
;
R 'is hydrogen or (C1-C20) alkyl;
R 7-1 is
Figure 112016014610913-pat00070
;
A 1 to A 3 and B 1 to B 3 independently of one another are (C3-C20) heteroarylene,
n or o is an integer from 1 to 3;
l, m, p and q are integers of 0 to 3;
T is Sn (R 51 ) (R 52 ) (R 53 ), R 51 to R 53 are (C1-C10) alkyl;
X is halogen;
The R group or a heteroaryl group, the alkyl of R 2 1, and A 1 to A 3, and The heteroarylene of B 1 to B 3 is selected from the group consisting of (C 1 -C 20) alkyl, (C 2 -C 20) alkenyl, (C 2 -C 20) alkynyl, (C 1 -C 20) alkoxy, A hydroxyl group, a halogen group, a cyano group, a nitro group, a trifluoromethyl group, and a silyl group.
제 6항 또는 제 7항에 있어서,
상기 화학식 4의 화합물은 하기 화학식 6로 표시되는 화합물을 화학식 7 또는 화학식 8과 반응시켜 제조되는 것을 특징으로 하는 유기 반도체 화합물을 제조하는 방법.
[화학식 6]
Figure 112016014610913-pat00064

[화학식 7]
(X1)Sn(R51)(R52)(R53)
[화학식 8]
(R54)(R55)(R56)Sn-Sn(R51)(R52)(R53)
[상기 화학식 6 내지 화학식 8에서,
Z는 S이고;
R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며;
R2는 (C1-C20)알킬이며,
X1는 할로겐이며;
R51 내지 R56 서로 독립적으로 (C1-C10)알킬이며;
상기 R1의 알킬 또는 헤테로아릴, 및 R2의 알킬은 (C1-C20)알킬, (C2-C20)알케닐, (C2-C20)알키닐, (C1-C20)알콕시, 아미노기, 하이드록시기, 할로겐기, 사이아노기, 나이트로기, 트리플루오로메틸기 및 실릴기로 선택되는 하나 이상의 치환기로 더 치환될 수 있다.]
8. The method according to claim 6 or 7,
Wherein the compound of Formula 4 is prepared by reacting a compound of Formula 6 with a compound of Formula 7 or Formula 8.
[Chemical Formula 6]
Figure 112016014610913-pat00064

(7)
(X 1 ) Sn (R 51 ) (R 52 ) (R 53 )
[Chemical Formula 8]
( R57 ) ( R56 ) ( R56 ) Sn-Sn ( R51 ) ( R52 ) ( R53 )
[In the above Chemical Formulas 6 to 8,
Z is S;
R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl;
R 2 is (C 1 -C 20) alkyl,
X 1 is halogen;
R 51 - R 56 is Independently of one another are (C1-C10) alkyl;
Alkyl or heteroaryl, and alkyl of R 2 of the R 1 is a (C1-C20) alkyl, (C2-C20) alkenyl, (C2-C20) alkynyl, (C1-C20) alkoxy, an amino group, a hydroxyl group , A halogen group, a cyano group, a nitro group, a trifluoromethyl group, and a silyl group.
제 6항 또는 제 7항에 있어서,
상기 화학식 6은 하기 화학식 9로 표시되는 화합물과 하기 화학식 10를 반응시켜 하기 화학식 11을 제조하는 단계; 및
상기 화학식 11을 하기 화학식 12과 반응시켜 상기 화학식 6을 제조하는 단계;를 포함하는 상기 화학식 1로 표시되는 유기 반도체 화합물의 제조방법.
[화학식 9]
Figure 112016014610913-pat00065

[화학식 10]
R1MX2
[화학식 11]
Figure 112016014610913-pat00066

[화학식 12]
R2X3
[상기 화학식 9 내지 12에서,
Z는 S이며;
R1은 (C1-C20)알킬 또는 (C3-C20)헤테로아릴이며;
R2는 (C1-C20)알킬이며,
M은 알칼리토금속이며;
X2 또는 X3은 할로겐이며;
상기 R1의 알킬 또는 헤테로아릴 및 R2의 알킬은 할로겐, (C1-C10)알킬, (C1-C10)알콕시, 아미노, 하이드록시 또는 나이트로에서 선택되는 하나이상으로 더 치환될 수 있다.]
8. The method according to claim 6 or 7,
(6) is prepared by reacting a compound represented by the following formula (9) with the following formula (10) And
And reacting the compound of formula (11) with a compound of formula (12) to produce the compound of formula (6).
[Chemical Formula 9]
Figure 112016014610913-pat00065

[Chemical formula 10]
R 1 MX 2
(11)
Figure 112016014610913-pat00066

[Chemical Formula 12]
R 2 X 3
[In the above formulas (9) to (12)
Z is S;
R 1 is (C 1 -C 20) alkyl or (C 3 -C 20) heteroaryl;
R 2 is (C 1 -C 20) alkyl,
M is an alkaline earth metal;
X 2 or X 3 is halogen;
The alkyl or heteroaryl of R 1 and the alkyl of R 2 may be further substituted with one or more of halogen, (C 1 -C 10) alkyl, (C 1 -C 10) alkoxy, amino, hydroxy or nitro.
제 5항에 따른 유기 반도체 화합물을 함유하는 유기 반도체 장치.An organic semiconductor device comprising an organic semiconductor compound according to claim 5.
KR1020140060387A 2013-05-21 2014-05-20 small molecule asymmetric organic semiconductor compounds, its manufacturing method and organic semiconductor device using the same KR101694961B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130057433 2013-05-21
KR1020130057433 2013-05-21

Publications (2)

Publication Number Publication Date
KR20140136892A KR20140136892A (en) 2014-12-01
KR101694961B1 true KR101694961B1 (en) 2017-01-10

Family

ID=52456991

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140060387A KR101694961B1 (en) 2013-05-21 2014-05-20 small molecule asymmetric organic semiconductor compounds, its manufacturing method and organic semiconductor device using the same

Country Status (1)

Country Link
KR (1) KR101694961B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170003234A (en) * 2015-06-30 2017-01-09 주식회사 엘지화학 Fused ring derivative and organic solar cell comprising the same
EP3401969B1 (en) 2016-06-08 2020-10-14 LG Chem, Ltd. Organic transistor and gas sensor
KR102176846B1 (en) * 2016-07-07 2020-11-10 주식회사 엘지화학 Heterocyclic compound and organic solar cell comprising the same
CN109354591B (en) * 2018-11-19 2021-09-14 中国科学院重庆绿色智能技术研究院 Active layer material of organic solar cell and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5544650B2 (en) 2008-11-21 2014-07-09 国立大学法人広島大学 Process for producing new compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Polym. Chem. 2011, 2, 2453-2461

Also Published As

Publication number Publication date
KR20140136892A (en) 2014-12-01

Similar Documents

Publication Publication Date Title
JP6797019B2 (en) Coupled polymers and devices incorporating them
KR101694961B1 (en) small molecule asymmetric organic semiconductor compounds, its manufacturing method and organic semiconductor device using the same
KR101986593B1 (en) Novel organic semiconductor compound, its production method and organic electronic device using them
KR102385317B1 (en) Three component copolymers for semiconductor, Preparation method thereof and Organic semiconductor device comprising the same
CN110776621B (en) D-pi-A type polymer containing quinoline-based fused ring unit and preparation method and application thereof
KR101484007B1 (en) new organic semiconductor compound and a method for manufacturing the same
KR102166994B1 (en) Three component copolymers for semiconductor, Preparation method thereof and Organic semiconductor device comprising the same
CN111533886A (en) Donor-receptor type polymer containing fused ring unit based on quinoxalinebenzotriazole and preparation method and application thereof
KR101595919B1 (en) organinc semiconductor compound and organic solar cell having them
CN109517142B (en) Star-shaped D-A structure conjugated molecule based on tri-indeno five-membered aromatic heterocycle, and preparation method and application thereof
KR102291239B1 (en) N-type organic semiconducting compounds, manufacturing method thereof, and organic photovoltaics containing the same
KR101707028B1 (en) Novel organic semiconductor compounds containing benzothiadiazole group, its manufacturing method and organic semiconductor device using the same
KR102114177B1 (en) Novel compound, its production method and organic electronic device using them
KR102331647B1 (en) Method for manufacturing hetero cyclic compounds for electron acceptor, polymers for electron donor based on the hetero cyclic compounds, and organic semiconductor device comprising the same
KR101934806B1 (en) Organic semiconductor compound, process for producing the organic semiconductor compound and organic semiconductor device using the same
KR101495152B1 (en) organic semiconductor compound, manufacturing method thereof, and organic electronic device that contains it
KR101317912B1 (en) Polymer with phenanthrothiadiazole thereof and photovoltaic device using same
KR102002396B1 (en) Novel organic semiconductor compound, its production method and organic electronic device using them
KR20180031272A (en) Hole transporting p-type polymers, light absorbing intrinsic semiconductor polymers, Organic photovoltaics comprising the same and Organic/Inorganic Hybrid Solar Cells comprising the same
KR101990300B1 (en) Novel polymer and organic electronic device containing the same
JP7029721B2 (en) Compounds, organic semiconductor materials, organic semiconductor devices, organic solar cells and organic transistors
KR101678415B1 (en) Novel organic semiconductor compound, preparation method thereof and organic electronic device having the same
KR101650758B1 (en) asymmetric organic semiconductor compound, process for producing thereof and organic semiconductor device using the same
CN103848968B (en) A kind of containing Thienopyrroles diketone-dibenzothiophene benzo two thiophen polymer and preparation and application thereof
KR101233822B1 (en) Polymer or derivatives with dioxidephenanthrothiadiazole thereof and photovoltaic device using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20200103

Year of fee payment: 4